NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. Summary of Significant Accounting Policies
Markel Corporation is a diverse financial holding company serving a variety of niche markets. Markel Corporation's principal business markets and underwrites specialty insurance products. Through its wholly owned subsidiary, Markel Ventures, Inc. (Markel Ventures), Markel Corporation also owns controlling interests in various businesses that operate outside of the specialty insurance marketplace. See note 2 for details regarding reportable segments.
a) Basis of Presentation. The accompanying consolidated financial statements have been prepared in accordance with United States (U.S.) generally accepted accounting principles (GAAP) and include the accounts of Markel Corporation and its consolidated subsidiaries, as well as any variable interest entities (VIEs) that meet the requirements for consolidation (the Company). All significant intercompany balances and transactions have been eliminated in consolidation. The Company consolidates the results of its Markel Ventures subsidiaries on a one-month lag, with the exception of significant transactions or events that occur during the intervening period. Certain prior period amounts have been reclassified to conform to the current period presentation.
b) Use of Estimates. The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities. Management periodically reviews its estimates and assumptions. Quarterly reviews include evaluating the adequacy of reserves for unpaid losses and loss adjustment expenses and contingencies. Estimates and assumptions for goodwill and intangible assets are reviewed in conjunction with an acquisition, and goodwill and indefinite-lived intangible assets are reassessed at least annually for impairment. Actual results may differ materially from the estimates and assumptions used in preparing the consolidated financial statements.
c) Investments. Available-for-sale investments and equity securities are recorded at estimated fair value. Available-for-sale investments include fixed maturity securities and short-term investments. Fixed maturity securities include government and municipal bonds and mortgage-backed securities with original maturities of more than one year. Short-term investments include certificates of deposit, commercial paper, discount notes and treasury bills with original maturities of one year or less. Unrealized gains and losses on available-for-sale investments, net of income taxes, are included in other comprehensive income. Unrealized gains and losses on equity securities, net of income taxes, are included in net income as net investment gains or losses. The Company completes a detailed analysis each quarter to assess declines in the fair value of its available-for-sale investments. Any impairment losses on the Company's available-for-sale investments are recorded as an allowance, subject to reversal.
Premiums and discounts are amortized or accreted over the lives of the related fixed maturity securities as an adjustment to the yield using the effective interest method. Dividend and interest income are recognized when earned. Accrued interest receivable is excluded from both the estimated fair value and the amortized cost basis of available-for-sale securities and included within other assets on the Company's consolidated balance sheets. Any uncollectible accrued interest receivable is written off in the period it is deemed uncollectible. Realized investment gains or losses on available-for-sale investments are included in net income. Realized gains or losses from sales of available-for-sale investments are derived using the first-in, first-out method on the trade date.
See note 4 and note 5 for further details regarding the Company's investment portfolio.
d) Cash and Cash Equivalents. The Company considers all investments with original maturities of 90 days or less to be cash equivalents. The carrying value of the Company's cash and cash equivalents approximates fair value.
e) Restricted Cash and Cash Equivalents. Cash and cash equivalents that are restricted as to withdrawal or use are recorded as restricted cash and cash equivalents. The carrying value of the Company's restricted cash and cash equivalents approximates fair value.
f) Receivables. Receivables include amounts receivable from agents, brokers and insureds, which represent premiums that are both currently due and amounts not yet due on insurance and reinsurance policies. Premiums for insurance policies are generally due at inception. Premiums for reinsurance policies generally become due over the period of coverage based on the policy terms. Changes in the estimate of reinsurance premiums written will result in an adjustment to premiums receivable in
the period they are determined. Receivables also include amounts receivable from contracts with customers, which represent the Company's unconditional right to consideration for satisfying the performance obligations outlined in the contract.
The Company monitors credit risk associated with receivables, taking into consideration the fact that in certain instances in the Company's insurance operations credit risk may be reduced by the Company's right to offset loss obligations or unearned premiums against premiums receivable. An allowance is established for credit losses expected to be incurred over the life of the receivable, which is recorded net of this allowance. The allowance is charged to net income in the period the receivable is recorded and revised in subsequent periods to reflect changes in the Company's estimate of expected credit losses. See note 7 for further details regarding receivables.
g) Reinsurance Recoverables. Amounts recoverable from reinsurers are estimated in a manner consistent with the claim liability associated with the reinsured business. The Company evaluates the financial condition of its reinsurers and monitors concentration of credit risk to minimize its exposure to significant losses from individual reinsurers. To further reduce credit exposure on reinsurance recoverables, the Company has received collateral, including letters of credit and trust accounts, from certain reinsurers. Cash collateral related to these reinsurance agreements is available, without restriction, when the Company pays losses covered by the reinsurance agreements. An allowance is established for credit losses expected to be incurred over the life of the reinsurance recoverable, which is recorded net of this allowance. The allowance is charged to net income in the period the recoverable is recorded and revised in subsequent periods to reflect changes in the Company's estimate of expected credit losses. As of December 31, 2022 and 2021, the allowance for credit losses associated with the Company's reinsurance recoverables was not material to the consolidated financial statements.
h) Deferred Policy Acquisition Costs. Costs directly related to the acquisition of insurance premiums are deferred and amortized over the related policy period, generally one year. The Company only defers acquisition costs incurred that are related directly to the successful acquisition of new or renewal insurance contracts, including commissions to agents and brokers, salaries and benefits and premium taxes. Commissions received related to reinsurance premiums ceded are netted against broker commissions in determining acquisition costs eligible for deferral. To the extent that future policy revenues on existing policies are not adequate to cover related costs and expenses, deferred policy acquisition costs are charged to earnings. The Company does not consider anticipated investment income in determining whether a premium deficiency exists. See note 2(a) and (f) for further details regarding policy acquisition costs, as well as note 24 for details regarding a change to the Company's policy for accounting for deferred policy acquisition costs.
i) Goodwill and Intangible Assets. Goodwill and intangible assets are recorded as a result of business acquisitions. Goodwill represents the excess of the amount paid to acquire a business over the net fair value of assets acquired and liabilities assumed at the date of acquisition. Indefinite-lived and other intangible assets are recorded at fair value as of the acquisition date. The determination of the fair value of certain assets acquired and liabilities assumed involves significant judgment and the use of valuation models and other estimates, which require assumptions that are inherently subjective. Goodwill and indefinite-lived intangible assets are tested for impairment at least annually. The Company completes an annual test during the fourth quarter of each year based upon the results of operations through September 30. Intangible assets with definite lives are amortized using the straight-line method over their estimated useful lives, generally five to 20 years, and are reviewed for impairment when events or circumstances indicate that their carrying value may not be recoverable. See note 8 for further details regarding goodwill and intangible assets.
j) Equity Method Investments. The Company holds certain investments that are required to be accounted for under the equity method, whereby they initially are recorded at cost within other assets on the consolidated balance sheets and subsequently increased or decreased by the Company's proportionate share of the net income or loss of the investee and other transactions impacting the investee's equity. The Company records its proportionate share of net income or loss of the investee in services and other revenues. The Company records its proportionate share of other comprehensive income or loss of the investee as a component of other comprehensive income. Dividends or other equity distributions in excess of the Company's cumulative equity in earnings of the investee are recorded as a reduction of the investment. The Company reviews equity method investments for impairment when events or circumstances indicate that a decline in the fair value of the investment below its carrying value is other-than-temporary. See note 6 for further details regarding the Company's equity method investments.
k) Property and Equipment. Property and equipment is maintained primarily by certain of the Company's Markel Ventures businesses and is stated at cost less accumulated depreciation. Depreciation of property and equipment is calculated using the straight-line method over the estimated useful lives of the respective assets. Property and equipment, net of accumulated depreciation, was $1.2 billion and $1.1 billion as of December 31, 2022 and 2021, respectively, and is included in other assets on the Company's consolidated balance sheets.
l) Leases. The present value of future lease payments for the Company's leases with terms greater than 12 months is included on the consolidated balance sheets as lease liabilities and right-of-use lease assets.
The Company's lease portfolio primarily consists of operating leases for real estate. Total expected lease payments are based on the lease payments specified in the contract and the stated term, including any options to extend or terminate that the Company is reasonably certain to exercise. The Company accounts for lease components and any associated non-lease components within a contract as a single lease component, and therefore allocates all of the expected lease payments to the lease component.
The lease liability, which represents the Company's contractual obligation to make lease payments, is calculated based on the present value of expected lease payments over the remaining lease term, discounted using the Company's collateralized incremental borrowing rate at the lease commencement date. The lease liability is then adjusted for any prepaid rent, lease incentives received or capitalized initial direct costs to determine the lease asset, which represents the Company's right to use the underlying asset for the lease term. Lease liabilities and lease assets are included in other liabilities and other assets, respectively, on the Company's consolidated balance sheets.
Total lease costs are primarily comprised of rental expense for operating leases, which is recognized on a straight line basis over the lease term. Rental expense attributable to the Company's underwriting operations is included in underwriting, acquisition and insurance expenses and rental expense attributable to the Company's other operations is included in products expenses and services and other expenses in the consolidated statements of income and comprehensive income. See note 9 for further details regarding leases.
m) Inventories. Inventories are maintained at certain of the Company's Markel Ventures businesses and consist primarily of raw materials, work-in-process and finished goods. Inventories are generally valued using the first-in-first-out method and stated at the lower of cost or net realizable value. Inventories were $639.6 million and $529.3 million as of December 31, 2022 and 2021, respectively, and are included in other assets on the Company's consolidated balance sheets.
n) Redeemable Noncontrolling Interests. The Company owns controlling interests in various companies through its Markel Ventures operations. In some cases, the Company has the option to acquire the remaining equity interests, and the remaining equity interests have the option to sell their interests to the Company, in the future. The redemption value of the remaining equity interests is generally based on the respective company's earnings in specified periods preceding the redemption date. The redeemable noncontrolling interests are currently redeemable or become redeemable between 2023 and 2032.
The Company recognizes changes in the redemption value that exceed the carrying value of redeemable noncontrolling interests to retained earnings as if the balance sheet date was also the redemption date. Changes in the redemption value also result in an adjustment to net income to common shareholders in the calculation of basic and diluted net income per common share. See note 19 for further details regarding the calculation of basic and diluted net income per common share.
o) Income Taxes. The Company records deferred income taxes to reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and their tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in years in which those temporary differences are expected to be recovered or settled. Deferred tax assets are reduced by a valuation allowance when management believes it is more likely than not that some, or all, of the deferred tax assets will not be realized. The Company recognizes the tax benefit from an uncertain tax position taken or expected to be taken in income tax returns only if it is more likely than not that the tax position will be sustained upon examination by tax authorities, based on the technical merits of the position. Tax positions that meet the more likely than not threshold are then measured using a probability weighted approach, whereby the largest amount of tax benefit that is greater than 50% likely of being realized upon ultimate settlement is recognized. The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. See note 15 for further details regarding income taxes.
p) Unpaid Losses and Loss Adjustment Expenses. Unpaid losses and loss adjustment expenses on the Company's property and casualty insurance business are based on evaluations of reported claims and estimates for losses and loss adjustment expenses incurred but not reported. Estimates for losses and loss adjustment expenses incurred but not reported are based on reserve development studies, among other things. Recorded reserves are estimates, and the ultimate liability may be greater or less than the estimates. See note 11 for further details regarding unpaid losses and loss adjustment expenses.
q) Life and Annuity Benefits. The Company has a run-off block of life and annuity reinsurance contracts that subject the Company to mortality, longevity and morbidity risks. The assumptions used to determine policy benefit reserves are generally
locked-in for the life of the contract unless an unlocking event occurs. To the extent existing policy reserves, together with the present value of future gross premiums and expected investment income earned thereon, are not adequate to cover the present value of future benefits, settlement and maintenance costs, the locked-in assumptions are revised to current best estimate assumptions and a charge to earnings for life and annuity benefits is recognized at that time. Because of the assumptions and estimates used in establishing reserves for life and annuity benefit obligations and the long-term nature of these reinsurance contracts, the ultimate liability may be greater or less than the estimates. Results attributable to the run-off of life and annuity reinsurance contracts are included in services and other revenues and services and other expenses in the Company's consolidated statements of income and comprehensive income. Investment income earned on the investments that support the policy benefit reserves are included in net investment income. See note 13 for further details regarding life and annuity benefits and note 1(x) for information on changes to the accounting for life and annuity benefits beginning in 2023.
r) Revenue Recognition.
Property and Casualty Premiums
Insurance premiums written are generally recorded at the inception of a policy and earned on a pro rata basis over the policy period, typically one year. The cost of reinsurance ceded is initially recorded as prepaid reinsurance premiums and is amortized over the reinsurance contract period in proportion to the amount of insurance protection provided. Premiums ceded are netted against premiums written. For multi-year contracts where insurance premiums are payable in annual installments, written premiums are recorded at the inception of the contract based on management's best estimate of total premiums to be received. For contracts where the cedent has the ability to unilaterally commute or cancel coverage within the term of the policy, premiums are generally recorded on an annual basis or up to the contract cancellation point. The remaining premiums are estimated and included as written at each successive anniversary date within the multi-year term.
Assumed reinsurance premiums are recorded at the inception of each contract based upon contract terms and information received from cedents and brokers and are earned on a pro rata basis over the coverage period, or for multi-year contracts, in proportion with the underlying risk exposure to the extent there is variability in the exposure through the coverage period. Changes in reinsurance premium estimates are expected and may result in significant adjustments in any period. These estimates change over time as additional information regarding changes in underlying exposures is obtained. Any subsequent differences arising on such estimates are recorded as premiums written in the period they are determined and are earned on a pro rata basis over the coverage period, or immediately if the coverage period has ended. The Company uses the periodic method to account for assumed reinsurance from foreign reinsurers as a result of the sufficiency of the information provided by the reinsurer, which is consistent with its accounting for assumed reinsurance from U.S. reinsurers.
Certain contracts that the Company writes provide for reinstatement of coverage. Reinstatement premiums are the premiums for the restoration of the insurance or reinsurance limit of a contract to its full amount after a loss occurrence by the insured or reinsured. The Company accrues for reinstatement premiums resulting from losses recorded. Such accruals are based upon contractual terms and management judgment is involved with respect to the amount of losses recorded. Changes in estimates of losses recorded on contracts with reinstatement premium features will result in changes in reinstatement premiums based on contractual terms. Reinstatement premiums are recognized at the time losses are recorded and are generally earned on a pro rata basis over the remaining coverage period.
Other Revenues
Other revenues primarily relate to the Company's Markel Ventures, insurance-linked securities (ILS) and program services operations and consist of revenues from the sale of products and services. Revenues are recognized when, or as, control of the promised goods or services is transferred to the Company's customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Contracts with customers generally have an original term of one year or less. For contracts with customers that have an original term greater than one year, the Company recognizes revenue at the amount for which it has a right to invoice for the products delivered or services performed. Certain customers may receive volume rebates or credits for products and services, which are accounted for as variable consideration. The Company estimates these amounts based on the expected amount to be provided to the customer and reduces revenues recognized by a corresponding amount. The Company does not expect significant changes to its estimates of variable consideration over the term of the contracts.
Payment terms for products and services vary by the type of product or service offered and the location of the customer, and payment is typically received at or shortly after the point of sale. For certain products, the Company requires partial payment
in the form of a deposit before the products are delivered to the customer, which is included in other liabilities on the Company's consolidated balance sheets.
Through its Markel Ventures operations, the Company has several different businesses that manufacture or produce a variety of products, including ornamental plants, precast concrete, equipment used in baking systems, over-the-road transportation equipment, portable dredges, residential homes and flooring for the trucking industry. Most of the Company's product revenues are recognized when the products are shipped to the customer or the products arrive at the agreed upon destination with the end customer. Some of the Company's contracts include multiple performance obligations. For such arrangements, revenues are allocated to each performance obligation based on the relative standalone selling price, which is derived from amounts stated in the contract.
Through its Markel Ventures operations, the Company also has several different businesses that provide various types of services, including distribution of exterior building products, fire protection and life safety services and consulting services. Service revenues are generally recognized over the term of the contracts based on hours incurred or as services are provided.
The Company's other revenues also include investment management fee income and through 2022, managing general agent (MGA) commissions for services provided through the Company's ILS operations. Investment management fee income is recognized over the period in which investment management services are provided and is calculated and recognized monthly, typically based on the net asset value of the accounts managed. For certain accounts, the Company is also entitled to participate, on a fixed-percentage basis, in any net income generated in excess of an agreed-upon threshold as established by the underlying investment management agreements. In general, net income is calculated at the end of each calendar year and incentive fees are payable annually. Incentive fee income is recognized at the conclusion of the contractual performance period, when the uncertainty related to performance has been resolved. MGA commissions are based on the direct written premiums of the insurance contracts placed. Commissions received for these services are generally recognized when the related policy is written.
Program services fees, or ceding fees, received in exchange for providing access to the U.S. property and casualty insurance market are based on the gross premiums written on behalf of general agent and capacity provider clients. Ceding fees are earned in a manner consistent with the recognition of the gross premiums earned on the underlying insurance policies, generally on a pro rata basis over the terms of the underlying policies reinsured.
See note 10 for further details regarding products, services and other revenues.
s) Program Services. In connection with its program services business, the Company enters into contractual agreements with both producing general agents and reinsurers, whereby the general agents and reinsurers are typically obligated to each other for payment of insurance amounts, including premiums, commissions and losses. To the extent these funds are not the obligation of the Company and are settled directly between the general agent and the reinsurer, no receivables or payables are recorded for these amounts. All obligations of the Company's insurance subsidiaries owed to or on behalf of their policyholders are recorded by the Company and, to the extent appropriate, offsetting reinsurance recoverables are recorded.
t) Foreign Currency Transactions. The U.S. Dollar is the Company's reporting currency and the primary functional currency of its foreign underwriting operations. The functional currencies of the Company's other foreign operations are the currencies of the primary economic environments in which the majority of their business is transacted.
Foreign currency transaction gains and losses are the result of exchange rate changes on transactions denominated in currencies other than the functional currency at each foreign entity. Monetary assets and liabilities are remeasured to the functional currency at current exchange rates, with resulting gains and losses included in net foreign exchange gains within net income. Non-monetary assets and liabilities are remeasured to the functional currency at historic exchange rates. Available-for-sale securities are recorded at fair value with resulting gains and losses, including the portion attributable to movements in exchange rates, included in the change in net unrealized gains on available-for-sale investments, net of taxes within other comprehensive income. While the Company attempts to naturally hedge its exposure to foreign currency fluctuations by matching assets and liabilities in the same currencies, there is a financial statement mismatch between the gains or losses recorded in net income related to insurance reserves denominated in non-functional currencies and the gains or losses recorded in other comprehensive income related to the available-for-sale securities held in non-functional currencies supporting the reserves.
Assets and liabilities of foreign operations denominated in a functional currency other than the U.S. Dollar are translated into the U.S. Dollar at current exchange rates, with resulting gains or losses included, net of taxes, in the change in foreign
currency translation adjustments within other comprehensive income. See note 20 for further details regarding the components of other comprehensive income.
u) Comprehensive Income. Comprehensive income represents all changes in equity that result from recognized transactions and other economic events during the period. Other comprehensive income refers to revenues, expenses, gains and losses that under U.S. GAAP are included in comprehensive income but excluded from net income, such as unrealized gains or losses on available-for-sale investments, foreign currency translation adjustments and changes in net actuarial pension loss. See note 20 for further details regarding other comprehensive income.
v) Net Income Per Common Share. Basic net income per common share is computed by dividing adjusted net income to shareholders by the weighted average number of common shares outstanding during the year. Diluted net income per common share is computed by dividing adjusted net income to shareholders by the weighted average number of common shares and dilutive potential common shares outstanding during the year. See note 19 for further details regarding the calculation of basic and diluted net income per common share.
w) Variable Interest Entities. The Company determines whether it has relationships with entities defined as VIEs in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 810, Consolidation. Under this guidance, a VIE is consolidated by the variable interest holder that is determined to be the primary beneficiary.
An entity in which the Company holds a variable interest is a VIE if any of the following conditions exist: (a) the total equity investment at risk is not sufficient to permit the entity to finance its activities without additional subordinated financial support, (b) as a group, the holders of equity investment at risk lack either the direct or indirect ability through voting rights or similar rights to make decisions about an entity's activities that most significantly impact the entity's economic performance or the obligation to absorb the expected losses or right to receive the expected residual returns, or (c) the voting rights of some investors are disproportionate to their obligation to absorb the expected losses of the entity, their rights to receive the expected residual returns of the entity, or both and substantially all of the entity's activities either involve or are conducted on behalf of an investor with disproportionately few voting rights.
The primary beneficiary is defined as the variable interest holder that is determined to have the controlling financial interest as a result of having both (a) the power to direct the activities of a VIE that most significantly impact the economic performance of the VIE and (b) the obligation to absorb losses or right to receive benefits from the VIE that could potentially be significant to the VIE.
The Company determines whether an entity is a VIE at the inception of its variable interest in the entity and upon the occurrence of certain reconsideration events. The Company continually reassesses whether it is the primary beneficiary of VIEs in which it holds a variable interest. See note 17 for further details regarding the Company's involvement with VIEs.
x) Recent Accounting Pronouncements.
Accounting Standards Not Yet Adopted
In August 2018, the FASB issued Accounting Standards Update (ASU) No. 2018-12, Financial Services—Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts. The FASB subsequently issued several ASUs as amendments to ASU No. 2018-12. The standard requires insurance companies with long duration contracts to: (1) review and, if there is a change, update the assumptions used to measure expected cash flows at least annually; (2) update the discount rate assumption at each reporting date; and (3) enhance certain qualitative and quantitative disclosures. ASU No. 2018-12 becomes effective for the Company during the first quarter of 2023 and will be applied using a modified retrospective approach that requires restatement of prior periods presented, including a cumulative adjustment to accumulated other comprehensive income as of January 1, 2021 (the transition date). The standard will, among other things, impact the discount rate used in estimating reserves for the Company's life and annuity reinsurance portfolio, which is in runoff. Currently, the discount rate assumption is locked-in for the life of the contracts, unless there is a loss recognition event. The adoption of ASU 2018-12 will result in a decrease to accumulated other comprehensive income of $15.3 million, net of taxes, as a result of changing the discount rate assumption as of January 1, 2021. However, the cumulative impact of changes in the discount rate assumption through the January 1, 2023 adoption date is based on the discount rate assumption determined as of the adoption date. Based on increases in interest rates between the transition date and the adoption date, the cumulative increase to accumulated other comprehensive income as of January 1, 2023 will be $89.6 million, net of taxes.
In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which becomes effective for the Company during the first quarter of 2023. ASU No. 2021-08 requires contract assets and liabilities accounted for under FASB ASC 606, Revenue from Contracts with Customers, to be recorded at the acquisition date as if the acquirer entered into those contracts itself on the contract inception dates, rather than at fair value. At adoption, ASU No. 2021-08 will not impact the Company's financial position, results of operations or cash flows, but prospectively, this ASU will impact amounts recorded by the Company for assets acquired and liabilities assumed in conjunction with certain acquisitions.
2. Segment Reporting Disclosures
The chief operating decision maker reviews the Company's ongoing underwriting operations on a global basis in the following two segments: Insurance and Reinsurance. In determining how to allocate resources and assess the performance of the Company's underwriting results, management considers many factors, including the nature of the insurance product sold, the type of account written and the type of customer served. The Insurance segment includes all direct business and facultative placements written on a risk-bearing basis within the Company's underwriting operations. The Reinsurance segment includes all treaty reinsurance written on a risk-bearing basis within the Company's underwriting operations. All investing activities related to the Company's insurance operations are included in the Investing segment.
The chief operating decision maker reviews and assesses Markel Ventures' performance in the aggregate, as a single operating segment. The Markel Ventures segment primarily consists of controlling interests in a diverse portfolio of businesses that operate in various industries.
The Company's other operations primarily consist of the results of the Company's insurance-linked securities operations and program services business. Other operations also include results for lines of business discontinued prior to, or in conjunction with, acquisitions, including development on asbestos and environmental loss reserves and results attributable to the run-off of life and annuity reinsurance business, which are monitored separately from the Company's ongoing underwriting operations. For purposes of segment reporting, none of these other operations are considered to be reportable segments.
Segment profit for each of the Company's underwriting segments is measured by underwriting profit. The property and casualty insurance industry commonly defines underwriting profit as earned premiums net of losses and loss adjustment expenses and underwriting, acquisition and insurance expenses. Underwriting profit does not replace operating income or net income computed in accordance with U.S. GAAP as a measure of profitability. Underwriting profit or loss provides a basis for management to evaluate the Company's underwriting performance. Segment profit for the Company's underwriting segments may also include other revenues and expenses that are attributable to the Company's underwriting operations that are not captured in underwriting profit. Segment profit for the Investing segment is measured by income from the Company's investment portfolio, which is comprised of net investment income and net investment gains. Segment profit for the Investing segment also includes income from equity method investments, which is included within services and other revenues. Segment profit for the Markel Ventures segment is measured by operating income.
For management reporting purposes, the Company allocates assets to its underwriting operations and to its Investing and Markel Ventures segments and certain of its other operations, including its insurance-linked securities and program services operations. Underwriting assets include assets attributed to the Company's Insurance and Reinsurance segments, discontinued underwriting lines of business, as well as assets that are not specifically allocated to the Company's other operations. Generally, the Company manages its underwriting assets in the aggregate and therefore does not allocate assets to individual underwriting segments.
a) The following tables summarize the Company's segment disclosures.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Year Ended December 31, 2022 |
(dollars in thousands) | Insurance | | Reinsurance | | Investing | | Markel Ventures | | Other (1) | | Consolidated |
Gross premium volume | $ | 8,606,700 | | | $ | 1,229,851 | | | $ | — | | | $ | — | | | $ | 3,365,131 | | | $ | 13,201,682 | |
Net written premiums | 7,040,176 | | | 1,167,312 | | | — | | | — | | | (4,098) | | | 8,203,390 | |
| | | | | | | | | | | |
Earned premiums | 6,528,263 | | | 1,063,347 | | | — | | | — | | | (3,818) | | | 7,587,792 | |
Losses and loss adjustment expenses: | | | | | | | | | | | |
Current accident year | (3,936,425) | | | (676,610) | | | — | | | — | | | — | | | (4,613,035) | |
Prior accident years | 142,924 | | | 26,052 | | | — | | | — | | | (1,530) | | | 167,446 | |
Underwriting, acquisition and insurance expenses: | | | | | | | | | | | |
Amortization of policy acquisition costs | (1,375,539) | | | (279,567) | | | — | | | — | | | — | | | (1,655,106) | |
Other underwriting expenses | (809,352) | | | (49,363) | | | — | | | — | | | (1,762) | | | (860,477) | |
Underwriting profit (loss) | 549,871 | | | 83,859 | | | — | | | — | | | (7,110) | | | 626,620 | |
Net investment income | — | | | — | | | 445,846 | | | 909 | | | — | | | 446,755 | |
Net investment losses | — | | | — | | | (1,595,733) | | | — | | | — | | | (1,595,733) | |
Products revenues | — | | | — | | | — | | | 2,427,096 | | | — | | | 2,427,096 | |
Services and other revenues | — | | | — | | | (17,661) | | | 2,329,522 | | | 497,564 | | | 2,809,425 | |
Products expenses | — | | | — | | | — | | | (2,241,736) | | | — | | | (2,241,736) | |
Services and other expenses | — | | | — | | | — | | | (2,111,510) | | | (195,125) | | | (2,306,635) | |
Amortization of intangible assets (2) | — | | | — | | | — | | | (79,043) | | | (99,735) | | | (178,778) | |
Impairment of goodwill | — | | | — | | | — | | | — | | | (80,000) | | | (80,000) | |
Segment profit (loss) | $ | 549,871 | | | $ | 83,859 | | | $ | (1,167,548) | | | $ | 325,238 | | | $ | 115,594 | | | $ | (92,986) | |
Interest expense | | | | | | | | | | | (196,062) | |
Net foreign exchange gains | | | | | | | | | | | 140,209 | |
| | | | | | | | | | | |
Loss before income taxes | | | | | | | | | | | $ | (148,839) | |
(1) Other represents the total profit (loss) attributable to the Company's operations that are not included in a reportable segment, as well as amortization of intangible assets attributable to the underwriting segments, which is not allocated between the Insurance and Reinsurance segments.
(2) Segment profit for the Markel Ventures segment includes amortization of intangible assets attributable to Markel Ventures. Amortization of intangible assets attributable to the Company's underwriting segments, included in Other, was $38.5 million for the year ended December 31, 2022.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Year Ended December 31, 2021 |
(dollars in thousands) | Insurance | | Reinsurance | | Investing | | Markel Ventures | | Other (1) | | Consolidated |
Gross premium volume | $ | 7,239,676 | | | $ | 1,246,143 | | | $ | — | | | $ | — | | | $ | 2,952,863 | | | $ | 11,438,682 | |
Net written premiums | 5,998,890 | | | 1,126,167 | | | — | | | — | | | (5,326) | | | 7,119,731 | |
| | | | | | | | | | | |
Earned premiums | 5,465,284 | | | 1,042,048 | | | — | | | — | | | (4,303) | | | 6,503,029 | |
Losses and loss adjustment expenses: | | | | | | | | | | | |
Current accident year | (3,311,185) | | | (749,815) | | | — | | | — | | | — | | | (4,061,000) | |
Prior accident years | 506,292 | | | (19,928) | | | — | | | — | | | (6,569) | | | 479,795 | |
Underwriting, acquisition and insurance expenses: | | | | | | | | | | | |
Amortization of policy acquisition costs | (1,153,049) | | | (266,217) | | | — | | | — | | | — | | | (1,419,266) | |
Other underwriting expenses | (810,929) | | | (61,326) | | | — | | | — | | | (2,218) | | | (874,473) | |
Underwriting profit (loss) | 696,413 | | | (55,238) | | | — | | | — | | | (13,090) | | | 628,085 | |
Net investment income | — | | | — | | | 367,406 | | | 11 | | | — | | | 367,417 | |
Net investment gains | — | | | — | | | 1,978,534 | | | — | | | — | | | 1,978,534 | |
Products revenues | — | | | — | | | — | | | 1,712,120 | | | — | | | 1,712,120 | |
Services and other revenues | — | | | — | | | 7,184 | | | 1,931,696 | | | 346,445 | | | 2,285,325 | |
Products expenses | — | | | — | | | — | | | (1,544,506) | | | — | | | (1,544,506) | |
Services and other expenses | — | | | 109 | | | — | | | (1,769,201) | | | (253,843) | | | (2,022,935) | |
Amortization of intangible assets (2) | — | | | — | | | — | | | (57,568) | | | (102,971) | | | (160,539) | |
| | | | | | | | | | | |
Segment profit (loss) | $ | 696,413 | | | $ | (55,129) | | | $ | 2,353,124 | | | $ | 272,552 | | | $ | (23,459) | | | $ | 3,243,501 | |
Interest expense | | | | | | | | | | | (183,579) | |
Net foreign exchange gains | | | | | | | | | | | 72,271 | |
| | | | | | | | | | | |
Income before income taxes | | | | | | | | | | | $ | 3,132,193 | |
(1) Other represents the total profit (loss) attributable to the Company's operations that are not included in a reportable segment, as well as amortization of intangible assets attributable to the underwriting segments, which is not allocated between the Insurance and Reinsurance segments.
(2) Segment profit for the Markel Ventures segment includes amortization of intangible assets attributable to Markel Ventures. Amortization of intangible assets attributable to the Company's underwriting segments, included in Other, was $41.2 million for the year ended December 31, 2021.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Year Ended December 31, 2020 |
(dollars in thousands) | Insurance | | Reinsurance | | Investing | | Markel Ventures | | Other (1) | | Consolidated |
Gross premium volume | $ | 6,029,024 | | | $ | 1,130,923 | | | $ | — | | | $ | — | | | $ | 2,106,718 | | | $ | 9,266,665 | |
Net written premiums | 4,977,662 | | | 960,123 | | | — | | | — | | | (5,547) | | | 5,932,238 | |
| | | | | | | | | | | |
Earned premiums | 4,688,448 | | | 929,348 | | | — | | | — | | | (5,591) | | | 5,612,205 | |
Losses and loss adjustment expenses: | | | | | | | | | | | |
Current accident year | (3,373,085) | | | (700,240) | | | — | | | — | | | — | | | (4,073,325) | |
Prior accident years | 554,586 | | | 51,755 | | | — | | | — | | | 23 | | | 606,364 | |
Underwriting, acquisition and insurance expenses: | | | | | | | | | | | |
Amortization of policy acquisition costs | (988,668) | | | (240,493) | | | — | | | — | | | — | | | (1,229,161) | |
Other underwriting expenses | (712,280) | | | (74,379) | | | — | | | — | | | (1,807) | | | (788,466) | |
Underwriting profit (loss) | 169,001 | | | (34,009) | | | — | | | — | | | (7,375) | | | 127,617 | |
Net investment income | — | | | — | | | 375,581 | | | 245 | | | — | | | 375,826 | |
Net investment gains | — | | | — | | | 617,979 | | | — | | | — | | | 617,979 | |
Products revenues | — | | | — | | | — | | | 1,439,515 | | | — | | | 1,439,515 | |
Services and other revenues | — | | | — | | | (3,996) | | | 1,355,199 | | | 338,338 | | | 1,689,541 | |
Products expenses | — | | | — | | | — | | | (1,256,159) | | | — | | | (1,256,159) | |
Services and other expenses | — | | | (41,461) | | | — | | | (1,232,150) | | | (287,509) | | | (1,561,120) | |
Amortization of intangible assets (2) | — | | | — | | | — | | | (52,572) | | | (106,743) | | | (159,315) | |
| | | | | | | | | | | |
Segment profit (loss) | $ | 169,001 | | | $ | (75,470) | | | $ | 989,564 | | | $ | 254,078 | | | $ | (63,289) | | | $ | 1,273,884 | |
Interest expense | | | | | | | | | | | (177,582) | |
Net foreign exchange losses | | | | | | | | | | | (95,853) | |
| | | | | | | | | | | |
Income before income taxes | | | | | | | | | | | $ | 1,000,449 | |
(1) Other represents the total profit (loss) attributable to the Company's operations that are not included in a reportable segment, as well as amortization of intangible assets attributable to the underwriting segments, which is not allocated between the Insurance and Reinsurance segments.
(2) Segment profit for the Markel Ventures segment includes amortization of intangible assets attributable to Markel Ventures. Amortization of intangible assets attributable to the Company's underwriting segments, included in Other, was $41.9 million for the year ended December 31, 2020.
b) The following amounts attributable to the Markel Ventures segment are also reviewed, or included in measures reviewed, by the Company's chief operating decision maker.
| | | | | | | | | | | | | | | | | |
| Years Ended December 31, |
(dollars in thousands) | 2022 | | 2021 | | 2020 |
Depreciation expense | $ | 102,055 | | | $ | 72,580 | | | $ | 60,284 | |
Interest expense (1) | $ | 46,780 | | | $ | 35,031 | | | $ | 46,664 | |
Income tax expense | $ | 61,588 | | | $ | 43,626 | | | $ | 45,815 | |
Capital expenditures | $ | 225,230 | | | $ | 124,451 | | | $ | 75,404 | |
(1) Interest expense for the years ended December 31, 2022, 2021 and 2020 included intercompany interest expense of $27.4 million, $25.8 million and $32.0 million, respectively, which was eliminated in consolidation.
c) The following table summarizes earned premiums by major product grouping within each underwriting segment.
| | | | | | | | | | | | | | | | | |
| Years Ended December 31, |
(dollars in thousands) | 2022 | | 2021 | | 2020 |
Insurance segment: | | | | | |
General liability | $ | 1,927,721 | | | $ | 1,564,221 | | | $ | 1,261,411 | |
Professional liability | 1,739,983 | | | 1,523,536 | | | 1,141,034 | |
Property | 428,563 | | | 362,637 | | | 356,934 | |
Marine and energy | 585,885 | | | 495,897 | | | 458,050 | |
Personal lines | 489,648 | | | 451,095 | | | 405,210 | |
Programs | 384,952 | | | 222,410 | | | 238,909 | |
Workers' compensation | 385,054 | | | 354,337 | | | 338,186 | |
Credit and surety | 193,701 | | | 161,155 | | | 151,397 | |
Other products | 392,756 | | | 329,996 | | | 337,317 | |
Total Insurance | 6,528,263 | | | 5,465,284 | | | 4,688,448 | |
Reinsurance segment: | | | | | |
Professional liability | 398,839 | | | 320,646 | | | 243,645 | |
General liability | 382,482 | | | 314,699 | | | 195,468 | |
Specialty | 275,033 | | | 276,943 | | | 298,267 | |
Property | 6,993 | | | 129,760 | | | 191,968 | |
Total Reinsurance | 1,063,347 | | | 1,042,048 | | | 929,348 | |
Other | (3,818) | | | (4,303) | | | (5,591) | |
Total earned premiums | $ | 7,587,792 | | | $ | 6,503,029 | | | $ | 5,612,205 | |
The Company does not manage products at this level of aggregation as it offers a diverse portfolio of products and manages these products in logical groupings within each underwriting segment.
During the years ended December 31, 2022, 2021 and 2020, 80%, 80% and 79%, respectively, of gross premiums written in the Company's underwriting segments were attributed to risks or cedents located in the United States. Substantially all of the gross premiums written in the Company's program services and other fronting businesses during 2022, 2021 and 2020 were attributed to risks located in the United States.
Most of the Company's gross written premiums are placed through insurance and reinsurance brokers. During the years ended December 31, 2022, 2021 and 2020, the Company's top three independent brokers accounted for 28%, 28% and 31% of gross premiums written in the Company's underwriting segments. During the years ended December 31, 2022, 2021 and 2020, the top three independent brokers accounted for 19%, 19% and 20%, respectively, of gross premiums written in the Insurance segment and 88%, 84% and 84%, respectively, of gross premiums written in the Reinsurance segment.
d) The following table summarizes total products revenues and services and other revenues by major product and service grouping within the Company's Markel Ventures segment.
| | | | | | | | | | | | | | | | | |
| Years Ended December 31, |
(dollars in thousands) | 2022 | | 2021 | | 2020 |
Products: | | | | | |
Consumer and building | $ | 1,510,130 | | | $ | 911,422 | | | $ | 814,697 | |
Transportation-related | 612,467 | | | 474,839 | | | 351,559 | |
Equipment manufacturing | 304,499 | | | 325,859 | | | 273,259 | |
Total products revenues | 2,427,096 | | | 1,712,120 | | | 1,439,515 | |
Services and other: | | | | | |
Construction | 1,910,403 | | | 1,554,592 | | | 915,696 | |
Consulting | 326,549 | | | 277,902 | | | 283,386 | |
Other | 92,570 | | | 99,202 | | | 156,117 | |
Total services and other revenues | 2,329,522 | | | 1,931,696 | | | 1,355,199 | |
Total products revenues and services and other revenues | $ | 4,756,618 | | | $ | 3,643,816 | | | $ | 2,794,714 | |
The Company does not manage the Markel Ventures portfolio of businesses at this level of aggregation due to the distinct characteristics of each business and the autonomy with which each business operates. Management reviews and assesses the performance of the Markel Ventures businesses in the aggregate at the Markel Ventures segment level, while individual management teams are responsible for developing strategic initiatives, managing day-to-day operations and making investment and capital allocation decisions for their respective companies.
During the years ended December 31, 2022, 2021 and 2020, the portion of Markel Ventures segment revenues attributable to U.S. operations was 96%, 95%, and 95%, respectively.
e) The following table reconciles segment assets to the Company's consolidated balance sheets.
| | | | | | | | | | | |
| December 31, |
(dollars in thousands) | 2022 | | 2021 |
Segment assets: | | | |
Investing | $ | 26,982,280 | | | $ | 28,277,801 | |
Underwriting | 8,853,559 | | | 8,111,316 | |
Markel Ventures | 5,315,677 | | | 4,958,279 | |
Total segment assets | 41,151,516 | | | 41,347,396 | |
Other operations | 8,639,743 | | | 7,129,700 | |
Total assets | $ | 49,791,259 | | | $ | 48,477,096 | |
f) The following table summarizes deferred policy acquisition costs, unearned premiums and unpaid losses and loss adjustment expenses.
| | | | | | | | | | | | | | | | | |
(dollars in thousands) | Deferred Policy Acquisition Costs | | Unearned Premiums | | Unpaid Losses and Loss Adjustment Expenses |
December 31, 2022 | | | | | |
Insurance segment | $ | 677,921 | | | $ | 4,015,252 | | | $ | 11,616,386 | |
Reinsurance segment | 247,562 | | | 921,541 | | | 3,581,699 | |
Other underwriting | — | | | 9,473 | | | 197,602 | |
Total underwriting | 925,483 | | | 4,946,266 | | | 15,395,687 | |
Program services and other fronting | — | | | 1,274,482 | | | 5,204,290 | |
Markel CATCo Re (see note 17) | — | | | — | | | 347,921 | |
Total | $ | 925,483 | | | $ | 6,220,748 | | | $ | 20,947,898 | |
December 31, 2021 | | | | | |
Insurance segment | $ | 574,181 | | | $ | 3,350,054 | | | $ | 10,051,994 | |
Reinsurance segment | 219,964 | | | 802,824 | | | 3,639,210 | |
Other underwriting | — | | | — | | | 271,356 | |
Total underwriting | 794,145 | | | 4,152,878 | | | 13,962,560 | |
Program services and other fronting | — | | | 1,230,741 | | | 4,216,334 | |
Total | $ | 794,145 | | | $ | 5,383,619 | | | $ | 18,178,894 | |
3. Acquisitions and Dispositions
Volante
In October 2022, the Company sold its controlling interest in its Volante managing general agent companies (Volante) for total consideration of $181.9 million, of which $155.6 million was cash. This transaction resulted in a gain of $118.5 million that was included in services and other revenue. Volante underwrites and administers specialty insurance and reinsurance policies and provides delegated underwriting services to third-party providers of insurance capital.
Velocity
In February 2022, the Company sold the majority of its controlling interest in its Velocity managing general agent companies (Velocity) for total cash consideration of $181.3 million, of which $165.6 million was received in 2022. This transaction resulted in a gain of $107.3 million that was included in services and other revenues. Velocity provides risk origination services for the Company's Nephila insurance-linked securities fund management operations, as well as for third parties. The Company retained a minority interest in Velocity that was recorded at fair value as of the transaction date ($47.4 million) and is accounted for under the equity method.
Metromont LLC
In December 2021, the Company acquired 51% of Metromont LLC (Metromont), a precast concrete manufacturer and concrete building solutions provider for commercial projects. Under the terms of the acquisition agreement, the Company has the option to acquire the remaining equity interests and the remaining equity holders have the option to sell their interests to the Company in the future. The redemption value of the remaining equity interests is generally based on Metromont's earnings in specified periods preceding the redemption date. Total consideration for the transaction was $274.5 million, all of which was cash.
As of December 31, 2021, the purchase price was preliminarily allocated to the acquired assets and liabilities of Metromont based on estimated fair value at the acquisition date. During 2022, the Company completed the process of determining the fair value of the assets acquired and liabilities assumed with Metromont and recognized goodwill of $101.6 million, intangible assets of $230.0 million and redeemable noncontrolling interests of $247.4 million. The final purchase price allocation reflected differences from the preliminary purchase price allocation, including an $86.1 million increase in the amount recognized for intangible assets upon completion of a third-party valuation and a $22.5 million decrease in the allocation to redeemable noncontrolling interests, all of which resulted in a $117.7 million decrease to goodwill from the preliminary amount recognized. Goodwill is primarily attributable to expected future earnings and cash flow potential of Metromont, of which the Company's share is deductible for income tax purposes. Intangible assets include $175.0 million of customer relationships and $55.0 million of trade names, which are being amortized over 17 years and 15 years, respectively. Results attributable to Metromont are included in the Company's Markel Ventures segment.
Buckner HeavyLift Cranes
In August 2021, the Company acquired 90% of the holding company for the Buckner HeavyLift Cranes companies (Buckner), a provider of crane rental services for large commercial contractors. Under the terms of the acquisition agreement, the Company has the option to acquire the remaining equity interests and the remaining equity holders have the option to sell their interests to the Company in the future. The redemption value of the remaining equity interests is generally based on Buckner's earnings in specified periods preceding the redemption dates. Total consideration for the transaction was $237.9 million, all of which was cash.
As of December 31, 2021, the purchase price was preliminarily allocated to the acquired assets and liabilities of Buckner based on estimated fair value at the acquisition date. During 2022, the Company completed the process of determining the fair value of the assets acquired and liabilities assumed with Buckner and recognized goodwill of $109.9 million, intangible assets of $60.0 million and fixed assets of $290.4 million, primarily related to cranes. The final purchase price allocation reflected differences from the preliminary purchase price allocation, including a $42.2 million decrease in the amount recognized for the cranes upon completion of a third-party valuation, which resulted in a $35.3 million net increase to goodwill from the preliminary amount recognized. Goodwill is primarily attributable to expected future earnings and cash flow potential of Buckner, and it is not deductible for income tax purposes. Intangible assets include $50.0 million of customer relationships and $10.0 million of trade names, which are being amortized over 7 years and 15 years, respectively. Additionally, the Company assumed long-term debt of $165.1 million and recognized redeemable noncontrolling interests of $26.4 million. Results attributable to Buckner are included in the Company's Markel Ventures segment.
Lansing Building Products, LLC
In April 2020, the Company acquired a controlling interest in Lansing Building Products, LLC, a supplier of exterior building products and materials to professional contractors throughout the U.S., which simultaneously acquired the distribution business of Harvey Building Products to enhance geographic reach and scale (together, Lansing), bringing the Company's ownership in Lansing to 91%. Under the terms of the acquisition agreement, the Company has the option to acquire the remaining equity interests and the remaining equity holders have the option to sell their interests to the Company in the future. The redemption value of the remaining equity interests is generally based on Lansing's earnings in specified periods preceding the redemption dates. Total consideration for both transactions was $559.2 million, all of which was cash.
The purchase price was allocated to the acquired assets and liabilities of Lansing based on estimated fair value at the acquisition date. The Company recognized goodwill of $287.1 million, which is primarily attributable to expected future earnings and cash flow potential of Lansing. The majority of the goodwill recognized is not deductible for income tax purposes. The Company also recognized other intangible assets of $210.0 million, which included $188.0 million of customer relationships and $22.0 million of trade names, which are being amortized over a weighted average period of 16 years and 14 years, respectively. The Company also recognized redeemable noncontrolling interests of $43.6 million. Results attributable to Lansing are included in the Company's Markel Ventures segment.
4. Investments
a) The following tables summarize the Company's available-for-sale investments. Commercial and residential mortgage-backed securities include securities issued by U.S. government-sponsored enterprises and U.S. government agencies. The net unrealized holding gains (losses) in the tables below are presented before taxes and any reserve deficiency adjustments for life and annuity benefit reserves. See note 13.
| | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2022 |
(dollars in thousands) | Amortized Cost | | Gross Unrealized Holding Gains | | Gross Unrealized Holding Losses | | | | Estimated Fair Value |
Fixed maturity securities: | | | | | | | | | |
U.S. Treasury securities | $ | 3,050,089 | | | $ | 2,363 | | | $ | (138,493) | | | | | $ | 2,913,959 | |
U.S. government-sponsored enterprises | 871,463 | | | 154 | | | (106,079) | | | | | 765,538 | |
Obligations of states, municipalities and political subdivisions | 3,973,911 | | | 6,503 | | | (247,231) | | | | | 3,733,183 | |
Foreign governments | 1,473,658 | | | 2,843 | | | (169,723) | | | | | 1,306,778 | |
Commercial mortgage-backed securities | 2,109,721 | | | 395 | | | (169,668) | | | | | 1,940,448 | |
Residential mortgage-backed securities | 553,591 | | | 6 | | | (26,804) | | | | | 526,793 | |
Asset-backed securities | 1,693 | | | — | | | (53) | | | | | 1,640 | |
Corporate bonds | 771,761 | | | 836 | | | (104,101) | | | | | 668,496 | |
Total fixed maturity securities | 12,805,887 | | | 13,100 | | | (962,152) | | | | | 11,856,835 | |
Short-term investments | 2,663,560 | | | 5,760 | | | (58) | | | | | 2,669,262 | |
Investments, available-for-sale | $ | 15,469,447 | | | $ | 18,860 | | | $ | (962,210) | | | | | $ | 14,526,097 | |
| | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2021 |
(dollars in thousands) | Amortized Cost | | Gross Unrealized Holding Gains | | Gross Unrealized Holding Losses | | Estimated Fair Value |
Fixed maturity securities: | | | | | | | |
U.S. Treasury securities | $ | 2,489,032 | | | $ | 2,633 | | | $ | (21,471) | | | $ | 2,470,194 | |
U.S. government-sponsored enterprises | 753,029 | | | 28,997 | | | (6,439) | | | 775,587 | |
Obligations of states, municipalities and political subdivisions | 4,007,211 | | | 266,575 | | | (7,862) | | | 4,265,924 | |
Foreign governments | 1,394,771 | | | 134,071 | | | (9,488) | | | 1,519,354 | |
Commercial mortgage-backed securities | 1,928,775 | | | 69,810 | | | (8,152) | | | 1,990,433 | |
Residential mortgage-backed securities | 699,136 | | | 27,084 | | | (170) | | | 726,050 | |
Asset-backed securities | 3,035 | | | 46 | | | — | | | 3,081 | |
Corporate bonds | 786,478 | | | 54,475 | | | (4,271) | | | 836,682 | |
Total fixed maturity securities | 12,061,467 | | | 583,691 | | | (57,853) | | | 12,587,305 | |
Short-term investments | 1,805,300 | | | 28 | | | (5,340) | | | 1,799,988 | |
Investments, available-for-sale | $ | 13,866,767 | | | $ | 583,719 | | | $ | (63,193) | | | $ | 14,387,293 | |
b) The following tables summarize gross unrealized investment losses on available-for-sale investments by the length of time that securities have continuously been in an unrealized loss position.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2022 |
| Less than 12 months | | 12 months or longer | | Total |
(dollars in thousands) | Estimated Fair Value | | Gross Unrealized Holding Losses | | Estimated Fair Value | | Gross Unrealized Holding Losses | | Estimated Fair Value | | Gross Unrealized Holding Losses |
Fixed maturity securities: | | | | | | | | | | | |
U.S. Treasury securities | $ | 735,605 | | | $ | (30,583) | | | $ | 1,907,922 | | | $ | (107,910) | | | $ | 2,643,527 | | | $ | (138,493) | |
U.S. government-sponsored enterprises | 413,495 | | | (40,488) | | | 331,391 | | | (65,591) | | | 744,886 | | | (106,079) | |
Obligations of states, municipalities and political subdivisions | 2,474,289 | | | (164,537) | | | 348,943 | | | (82,694) | | | 2,823,232 | | | (247,231) | |
Foreign governments | 900,322 | | | (115,324) | | | 300,423 | | | (54,399) | | | 1,200,745 | | | (169,723) | |
Commercial mortgage-backed securities | 1,611,603 | | | (117,482) | | | 305,217 | | | (52,186) | | | 1,916,820 | | | (169,668) | |
Residential mortgage-backed securities | 516,423 | | | (25,232) | | | 9,342 | | | (1,572) | | | 525,765 | | | (26,804) | |
Asset-backed securities | 1,640 | | | (53) | | | — | | | — | | | 1,640 | | | (53) | |
Corporate bonds | 496,766 | | | (74,542) | | | 153,035 | | | (29,559) | | | 649,801 | | | (104,101) | |
Total fixed maturity securities | 7,150,143 | | | (568,241) | | | 3,356,273 | | | (393,911) | | | 10,506,416 | | | (962,152) | |
Short-term investments | 774,480 | | | (58) | | | — | | | — | | | 774,480 | | | (58) | |
Total | $ | 7,924,623 | | | $ | (568,299) | | | $ | 3,356,273 | | | $ | (393,911) | | | $ | 11,280,896 | | | $ | (962,210) | |
At December 31, 2022, the Company held 1,400 available-for-sale securities in an unrealized loss position with a total estimated fair value of $11.3 billion and gross unrealized losses of $962.2 million. Of these 1,400 securities, 246 securities had been in a continuous unrealized loss position for one year or longer and had a total estimated fair value of $3.4 billion and gross unrealized losses of $393.9 million.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2021 |
| Less than 12 months | | 12 months or longer | | Total |
(dollars in thousands) | Estimated Fair Value | | Gross Unrealized Holding Losses | | Estimated Fair Value | | Gross Unrealized Holding Losses | | Estimated Fair Value | | Gross Unrealized Holding Losses |
Fixed maturity securities: | | | | | | | | | | | |
U.S. Treasury securities | $ | 2,236,637 | | | $ | (18,433) | | | $ | 97,173 | | | $ | (3,038) | | | $ | 2,333,810 | | | $ | (21,471) | |
U.S. government-sponsored enterprises | 381,495 | | | (5,640) | | | 14,010 | | | (799) | | | 395,505 | | | (6,439) | |
Obligations of states, municipalities and political subdivisions | 393,249 | | | (6,941) | | | 23,589 | | | (921) | | | 416,838 | | | (7,862) | |
Foreign governments | 322,813 | | | (8,596) | | | 25,564 | | | (892) | | | 348,377 | | | (9,488) | |
Commercial mortgage-backed securities | 345,616 | | | (7,765) | | | 9,189 | | | (387) | | | 354,805 | | | (8,152) | |
Residential mortgage-backed securities | 12,828 | | | (159) | | | 269 | | | (11) | | | 13,097 | | | (170) | |
| | | | | | | | | | | |
Corporate bonds | 193,786 | | | (4,271) | | | — | | | — | | | 193,786 | | | (4,271) | |
Total fixed maturity securities | 3,886,424 | | | (51,805) | | | 169,794 | | | (6,048) | | | 4,056,218 | | | (57,853) | |
Short-term investments | 228,870 | | | (5,340) | | | — | | | — | | | 228,870 | | | (5,340) | |
Total | $ | 4,115,294 | | | $ | (57,145) | | | $ | 169,794 | | | $ | (6,048) | | | $ | 4,285,088 | | | $ | (63,193) | |
At December 31, 2021, the Company held 277 available-for-sale securities in an unrealized loss position with a total estimated fair value of $4.3 billion and gross unrealized losses of $63.2 million. Of these 277 securities, 13 securities had been in a continuous unrealized loss position for one year or longer and had a total estimated fair value of $169.8 million and gross unrealized losses of $6.0 million.
The Company completes a detailed analysis each quarter to assess whether the decline in the fair value of any investment below its cost basis is the result of a credit loss. All available-for-sale securities with unrealized losses are reviewed. The Company considers many factors in completing its quarterly review of securities with unrealized losses for credit-related impairment to determine whether a credit loss exists, including the extent to which fair value is below cost, the implied yield to maturity, rating downgrades of the security and whether or not the issuer has failed to make scheduled principal or interest payments. The Company also takes into consideration information about the financial condition of the issuer and industry factors that could negatively impact the capital markets.
If the decline in fair value of an available-for-sale security below its amortized cost is considered to be the result of a credit loss, the Company compares the estimated present value of the cash flows expected to be collected to the amortized cost of the security. The extent to which the estimated present value of the cash flows expected to be collected is less than the amortized cost of the security represents the credit loss, which is recorded as an allowance and recognized in net income. The allowance is limited to the difference between the fair value and the amortized cost of the security. Any remaining decline in fair value represents the non-credit portion of the impairment, which is recognized in other comprehensive income. The Company did not have an allowance for credit losses as of December 31, 2022 or 2021.
Quarterly, the Company also considers whether it intends to sell an available-for-sale security or if it is more likely than not that it will be required to sell a security before recovery of its amortized cost. In these instances, a decline in fair value is recognized in net income based on the fair value of the security at the time of assessment, resulting in a new cost basis for the security. As of December 31, 2022, the Company did not intend to sell or believe it would be required to sell any available-for-sale securities in an unrealized loss position before recovery of their amortized cost.
c) The amortized cost and estimated fair value of fixed maturity securities at December 31, 2022 are shown below by contractual maturity.
| | | | | | | | | | | |
(dollars in thousands) | Amortized Cost | | Estimated Fair Value |
Due in one year or less | $ | 1,363,418 | | | $ | 1,337,550 | |
Due after one year through five years | 3,926,756 | | | 3,708,752 | |
Due after five years through ten years | 3,115,913 | | | 2,787,686 | |
Due after ten years | 1,734,795 | | | 1,553,966 | |
| 10,140,882 | | | 9,387,954 | |
Commercial mortgage-backed securities | 2,109,721 | | | 1,940,448 | |
Residential mortgage-backed securities | 553,591 | | | 526,793 | |
Asset-backed securities | 1,693 | | | 1,640 | |
Total fixed maturity securities | $ | 12,805,887 | | | $ | 11,856,835 | |
Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties, and the holders may have the right to put the securities back to the issuer. Based on expected maturities, the estimated average duration of fixed maturity securities at December 31, 2022 was 3.9 years.
d) The following table presents the components of net investment income.
| | | | | | | | | | | | | | | | | |
| Years Ended December 31, |
(dollars in thousands) | 2022 | | 2021 | | 2020 |
Interest: | | | | | |
Fixed maturity securities | $ | 294,417 | | | $ | 283,366 | | | $ | 288,421 | |
Short-term investments | 33,493 | | | 2,475 | | | 6,400 | |
Cash and cash equivalents | 28,890 | | | 479 | | | 7,921 | |
Dividends on equity securities | 107,213 | | | 98,099 | | | 89,303 | |
| 464,013 | | | 384,419 | | | 392,045 | |
Investment expenses | (17,258) | | | (17,002) | | | (16,219) | |
Net investment income | $ | 446,755 | | | $ | 367,417 | | | $ | 375,826 | |
e) The following table presents the components of net investment gains (losses) included in net income (loss) and the change in net unrealized gains (losses) included in other comprehensive income (loss). Gross realized investment gains and losses on fixed maturity securities, short-term investments and other investments were not material to the consolidated financial statements and are presented on a net basis in the following table.
| | | | | | | | | | | | | | | | | |
| Years Ended December 31, |
(dollars in thousands) | 2022 | | 2021 | | 2020 |
Fixed maturity securities, short-term investments and other investments: | | | | | |
Net realized investment gains (losses) | $ | (40,983) | | | $ | 37,908 | | | $ | 14,780 | |
Equity securities: | | | | | |
Change in fair value of securities sold during the period | (14,884) | | | 25,902 | | | (470,008) | |
Change in fair value of securities held at the end of the period | (1,539,866) | | | 1,914,724 | | | 1,073,207 | |
Total change in fair value | (1,554,750) | | | 1,940,626 | | | 603,199 | |
Net investment gains (losses) | $ | (1,595,733) | | | $ | 1,978,534 | | | $ | 617,979 | |
Change in net unrealized gains (losses) on available-for-sale investments included in other comprehensive income (loss): | | | | | |
Fixed maturity securities | $ | (1,474,890) | | | $ | (504,133) | | | $ | 507,903 | |
Short-term investments | 11,014 | | | (8,951) | | | 2,344 | |
Reserve deficiency adjustment for life and annuity benefit reserves (see note 13) | 56,560 | | | 62,988 | | | (68,158) | |
Net increase (decrease) | $ | (1,407,316) | | | $ | (450,096) | | | $ | 442,089 | |
f) Total restricted assets are included on the Company's consolidated balance sheets as follows.
| | | | | | | | | | | |
| December 31, |
(dollars in thousands) | 2022 | | 2021 |
Investments | $ | 4,160,842 | | | $ | 4,403,414 | |
Restricted cash and cash equivalents | 1,084,081 | | | 902,457 | |
| | | |
Total | $ | 5,244,923 | | | $ | 5,305,871 | |
The following table presents the components of restricted assets.
| | | | | | | | | | | |
| December 31, |
(dollars in thousands) | 2022 | | 2021 |
Assets held in trust or on deposit to support underwriting activities | $ | 4,807,135 | | | $ | 4,895,627 | |
Assets pledged as security for letters of credit | 437,788 | | | 410,244 | |
Total | $ | 5,244,923 | | | $ | 5,305,871 | |
g) At December 31, 2022 and 2021, investments in securities issued by the U.S. Treasury, U.S. government agencies and U.S. government-sponsored enterprises were the only investments in any one issuer that exceeded 10% of shareholders' equity.
5. Fair Value Measurements
FASB ASC 820, Fair Value Measurements and Disclosures, establishes a three-level hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). If the inputs used to measure the assets or liabilities fall within different levels of the hierarchy, the classification is based on the lowest level input that is significant to the fair value measurement of the asset or liability.
Classification of assets and liabilities within the hierarchy considers the markets in which the assets and liabilities are traded and the reliability and transparency of the assumptions used to determine fair value. The hierarchy requires the use of observable market data when available. The levels of the hierarchy are defined as follows:
•Level 1 – Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities traded in active markets.
•Level 2 – Inputs to the valuation methodology include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability and market-corroborated inputs.
•Level 3 – Inputs to the valuation methodology are unobservable for the asset or liability and are significant to the fair value measurement.
In accordance with ASC 820, the Company determines fair value based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In determining fair value, the Company uses various methods, including the market, income and cost approaches. The Company uses valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. The following section describes the valuation methodologies used by the Company to measure assets and liabilities at fair value, including an indication of the level within the fair value hierarchy in which each asset or liability is generally classified.
Available-for-sale investments and equity securities. Available-for-sale investments and equity securities are recorded at fair value on a recurring basis. Available-for-sale investments include fixed maturity securities and short-term investments. Fair value is determined by the Company after considering various sources of information, including information provided by a third-party pricing service. The pricing service provides prices for substantially all of the Company's fixed maturity securities and equity securities. In determining fair value, the Company generally does not adjust the prices obtained from the pricing service. The Company obtains an understanding of the pricing service's valuation methodologies and related inputs, which include, but are not limited to, reported trades, benchmark yields, issuer spreads, bids, offers, duration, credit ratings, estimated cash flows and prepayment speeds. The Company validates prices provided by the pricing service by reviewing prices from other pricing sources and analyzing pricing data in certain instances.
The Company has evaluated the various types of securities in its investment portfolio to determine an appropriate fair value hierarchy level based upon trading activity and the observability of market inputs. Level 1 investments include those traded on an active exchange, such as the New York Stock Exchange. Level 2 investments include U.S. Treasury securities, U.S. government-sponsored enterprises, municipal bonds, foreign government bonds, commercial mortgage-backed securities, residential mortgage-backed securities, asset-backed securities and corporate debt securities. Level 3 investments include the Company's investments in insurance-linked securities funds that are not traded on an active exchange and are valued using unobservable inputs.
Fair value for available-for-sale investments and equity securities is measured based upon quoted prices in active markets, if available. Due to variations in trading volumes and the lack of quoted market prices, fixed maturity securities are classified as Level 2 investments. The fair value of fixed maturity securities is normally derived through recent reported trades for identical or similar securities, making adjustments through the reporting date based upon available market observable data previously described. If there are no recent reported trades, the fair value of fixed maturity securities may be derived through the use of matrix pricing or model processes, where future cash flow expectations are developed based upon collateral performance and discounted at an estimated market rate. Significant inputs used to determine the fair value of obligations of states, municipalities and political subdivisions, corporate bonds and obligations of foreign governments include reported trades, benchmark yields, issuer spreads, bids, offers, credit information and estimated cash flows. Significant inputs used to determine the fair value of commercial mortgage-backed securities, residential mortgage-backed securities and asset-backed securities include the type of underlying assets, benchmark yields, prepayment speeds, collateral information, tranche type and volatility, estimated cash flows, credit information, default rates, recovery rates, issuer spreads and the year of issue.
Due to the significance of unobservable inputs required in measuring the fair value of the Company's investments in certain insurance-linked securities funds, these investments are classified as Level 3 within the fair value hierarchy. The fair value of the securities is derived using their reported net asset value (NAV) as the primary input, as well as other observable and unobservable inputs as deemed necessary by management. Management has obtained an understanding of the inputs, assumptions, process and controls used to determine NAV, which is calculated by an independent third party. Unobservable inputs to the NAV calculations include assumptions around premium earnings patterns and loss reserve estimates for the underlying securitized reinsurance contracts. The Company's valuation policies and procedures for Level 3 investments are determined by management. Fair value measurements are analyzed quarterly to ensure the change in fair value from prior periods is reasonable relative to management's understanding of the underlying investments, recent market trends and external market data.
Senior long-term debt and other debt. Senior long-term debt and other debt is carried at amortized cost with the estimated fair value disclosed on the consolidated balance sheets. Senior long-term debt and other debt is classified as Level 2 within the fair value hierarchy due to variations in trading volumes and the lack of quoted market prices. Fair value is generally derived through recent reported trades, making adjustments through the reporting date, if necessary, based upon available market observable data including U.S. Treasury securities and implied credit spreads. Significant inputs used to determine the fair value of senior long-term debt and other debt include reported trades, benchmark yields, issuer spreads, bids and offers.
The following tables present the balances of assets measured at fair value on a recurring basis by level within the fair value hierarchy.
| | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2022 |
(dollars in thousands) | Level 1 | | Level 2 | | Level 3 | | Total |
Assets: | | | | | | | |
Investments: | | | | | | | |
Fixed maturity securities, available-for-sale: | | | | | | | |
U.S. Treasury securities | $ | — | | | $ | 2,913,959 | | | $ | — | | | $ | 2,913,959 | |
U.S. government-sponsored enterprises | — | | | 765,538 | | | — | | | 765,538 | |
Obligations of states, municipalities and political subdivisions | — | | | 3,733,183 | | | — | | | 3,733,183 | |
Foreign governments | — | | | 1,306,778 | | | — | | | 1,306,778 | |
Commercial mortgage-backed securities | — | | | 1,940,448 | | | — | | | 1,940,448 | |
Residential mortgage-backed securities | — | | | 526,793 | | | — | | | 526,793 | |
Asset-backed securities | — | | | 1,640 | | | — | | | 1,640 | |
Corporate bonds | — | | | 668,496 | | | — | | | 668,496 | |
Total fixed maturity securities, available-for-sale | — | | | 11,856,835 | | | — | | | 11,856,835 | |
Equity securities: | | | | | | | |
Insurance, banks and other financial institutions | 2,952,689 | | | — | | | 899 | | | 2,953,588 | |
Industrial, consumer and all other | 4,718,324 | | | — | | | — | | | 4,718,324 | |
Total equity securities | 7,671,013 | | | — | | | 899 | | | 7,671,912 | |
Short-term investments, available-for-sale | 2,510,164 | | | 159,098 | | | — | | | 2,669,262 | |
Total investments | $ | 10,181,177 | | | $ | 12,015,933 | | | $ | 899 | | | $ | 22,198,009 | |
| | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2021 |
(dollars in thousands) | Level 1 | | Level 2 | | Level 3 | | Total |
Assets: | | | | | | | |
Investments: | | | | | | | |
Fixed maturity securities, available-for-sale: | | | | | | | |
U.S. Treasury securities | $ | — | | | $ | 2,470,194 | | | $ | — | | | $ | 2,470,194 | |
U.S. government-sponsored enterprises | — | | | 775,587 | | | — | | | 775,587 | |
Obligations of states, municipalities and political subdivisions | — | | | 4,265,924 | | | — | | | 4,265,924 | |
Foreign governments | — | | | 1,519,354 | | | — | | | 1,519,354 | |
Commercial mortgage-backed securities | — | | | 1,990,433 | | | — | | | 1,990,433 | |
Residential mortgage-backed securities | — | | | 726,050 | | | — | | | 726,050 | |
Asset-backed securities | — | | | 3,081 | | | — | | | 3,081 | |
Corporate bonds | — | | | 836,682 | | | — | | | 836,682 | |
Total fixed maturity securities, available-for-sale | — | | | 12,587,305 | | | — | | | 12,587,305 | |
Equity securities: | | | | | | | |
Insurance, banks and other financial institutions | 3,307,755 | | | — | | | 56,472 | | | 3,364,227 | |
Industrial, consumer and all other | 5,659,700 | | | — | | | — | | | 5,659,700 | |
Total equity securities | 8,967,455 | | | — | | | 56,472 | | | 9,023,927 | |
Short-term investments, available-for-sale | 1,619,496 | | | 180,492 | | | — | | | 1,799,988 | |
Total investments | $ | 10,586,951 | | | $ | 12,767,797 | | | $ | 56,472 | | | $ | 23,411,220 | |
The following table summarizes changes in Level 3 investments measured at fair value on a recurring basis.
| | | | | | | | | | | |
(dollars in thousands) | 2022 | | 2021 |
Equity securities, beginning of period | $ | 56,472 | | | $ | 58,493 | |
Purchases | — | | | 18,900 | |
Sales | (56,335) | | | (15,015) | |
Net investment gains (losses) | 762 | | | (5,906) | |
Equity securities, end of period | $ | 899 | | | $ | 56,472 | |
Level 3 investments previously included the Company's investment in an insurance-linked securities fund managed by Markel CATCo Investment Management Ltd. (MCIM). In 2022, the Company's remaining investment was redeemed ($41.3 million) in conjunction with a buy-out transaction that provided for an accelerated return of all remaining capital to investors. See note 17 for further details about the Company's Markel CATCo operations and the buy-out transaction.
Except as disclosed in note 3 and note 8, the Company did not have any assets or liabilities measured at fair value on a non-recurring basis during the years ended December 31, 2022 and 2021.
6. Equity Method Investments
The Company holds certain investments that are accounted for under the equity method of accounting. The Company's equity method investments, which are included in other assets on the consolidated balance sheets, totaled $494.0 million and $459.7 million as of December 31, 2022 and 2021, respectively. The Company's proportionate share of earnings in its equity method investments was a loss of $22.9 million for the year ended December 31, 2022, income of $15.0 million for the year ended December 31, 2021 and a loss of $3.4 million for the year ended December 31, 2020.
The Company's most significant equity method investment is an investment in Hagerty, Inc. (Hagerty), which is accounted for on a quarter lag. Hagerty is an automotive enthusiast brand offering integrated membership products and programs as well as a specialty insurance provider focused on the global automobile enthusiast market. The Company's ownership interest in Hagerty was 23% as of December 31, 2022 and 2021. The Company's investment is comprised of Class A common shares, which are listed for trading on the New York Stock Exchange, as well as Class V common shares, associated with the
Company's original investment, that have special voting rights and can be converted on a one-for-one basis into Class A common shares. The Company accounts for its investment under the equity method as it is deemed to have the ability to exercise significant influence over Hagerty's operating and financial policies through a combination of its voting interest, its right to designate a board member and business it conducts with Hagerty. As of December 31, 2022 and 2021, the carrying value of the Company's investment in Hagerty was $245.1 million and $256.6 million, respectively.
As of December 31, 2022 and 2021, the estimated value of the Company's investment, based on the closing stock price of Hagerty's Class A common shares, was $656.0 million and $1.1 billion, respectively. See note 18 for further details regarding related party transactions with Hagerty.
7. Receivables
The following table presents the components of receivables.
| | | | | | | | | | | |
| December 31, |
(dollars in thousands) | 2022 | | 2021 |
Insurance | | | |
Amounts receivable from agents, brokers and insureds | $ | 2,176,295 | | | $ | 1,740,864 | |
Other insurance | 83,728 | | | 133,350 | |
Markel Ventures | 645,189 | | | 510,382 | |
Other | 77,961 | | | 50,379 | |
| 2,983,173 | | | 2,434,975 | |
Allowance for credit losses | (22,117) | | | (21,037) | |
Receivables | $ | 2,961,056 | | | $ | 2,413,938 | |
8. Goodwill and Intangible Assets
The following table presents a rollforward of the components of goodwill by reportable segment.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(dollars in thousands) | Insurance | | Reinsurance | | Markel Ventures | | Other(1) | | Total |
January 1, 2021 | $ | 772,700 | | | $ | 122,745 | | | $ | 901,045 | | | $ | 808,134 | | | $ | 2,604,624 | |
Acquisitions | — | | | — | | | 293,838 | | | — | | | 293,838 | |
| | | | | | | | | |
Foreign currency movements and other adjustments | 2,012 | | | — | | | 1,707 | | | (3,041) | | | 678 | |
December 31, 2021 (2) | $ | 774,712 | | | $ | 122,745 | | | $ | 1,196,590 | | | $ | 805,093 | | | $ | 2,899,140 | |
Acquisitions | — | | | — | | | 41,905 | | | — | | | 41,905 | |
Dispositions | — | | | — | | | — | | | (132,455) | | | (132,455) | |
Impairment of goodwill | — | | | — | | | — | | | (80,000) | | | (80,000) | |
Adjustments to preliminary purchase price allocation | — | | | — | | | (83,358) | | | — | | | (83,358) | |
Foreign currency movements and other adjustments | (3,084) | | | — | | | (1,228) | | | (2,082) | | | (6,394) | |
December 31, 2022 (2) | $ | 771,628 | | | $ | 122,745 | | | $ | 1,153,909 | | | $ | 590,556 | | | $ | 2,638,838 | |
(1) Amounts included in Other reflect the Company's operations that are not included in a reportable segment and are primarily related to the Company's program services and insurance-linked securities operations.
(2) As of December 31, 2022, goodwill was net of accumulated impairment losses of $190.6 million, of which $171.9 million was in Other and $18.7 million was in Markel Ventures. As of December 31, 2021, goodwill was net of accumulated impairment losses of $110.6 million, of which $91.9 million was in Other and $18.7 million was in Markel Ventures.
The Company completed its annual tests for goodwill and indefinite-lived intangible asset impairment as of October 1, 2022 based upon results of operations through September 30, 2022. See note 1 for further details regarding impairment testing. Impairment of goodwill was $80.0 million for the year ended December 31, 2022. There was no impairment of goodwill during 2021 or 2020 and no impairment of indefinite-lived intangible assets during 2022, 2021 or 2020.
The Company performed a quantitative impairment assessment for the Nephila reporting unit, which resulted in an $80.0 million impairment of goodwill, reducing the goodwill of the Nephila reporting unit to $221.8 million. The Company also evaluated the intangible assets within the Nephila reporting unit for impairment and determined they were not impaired.
The Company estimated the fair value of the Nephila reporting unit primarily using an income approach based on a discounted cash flow model. The cash flow projections used in the discounted cash flow model included the Company's best estimate of future growth and margins. The discount rates used to determine the fair value estimates were developed based on a capital asset pricing model using market-based inputs as well as an assessment of the inherent risk in projected future cash flows. The Company's fair value estimate was negatively impacted by an increase in the discount rate assumption in 2022, reflecting the increased cost of capital due to rising interest rates throughout 2022. Since acquiring Nephila in 2018, investment performance in the broader ILS market has been adversely impacted by consecutive years of elevated catastrophe losses, most recently with Hurricane Ian in 2022. These events, as well as recent volatility in the capital markets, have impacted investor decisions around allocation of capital to ILS, which in turn has impacted capital raises and redemptions within the funds Nephila manages. Following Hurricane Ian, Nephila has seen more favorable rates on the reinsurance contracts to which the Nephila Reinsurers subscribe, which is reflective of the current property catastrophe market and had a positive impact on Nephila's growth and performance projections. However, the impact of this favorable trend was more than offset by the impact of further declines in investor capital within the funds Nephila manages. Cash flow assumptions reflect the Company's best estimate of the reporting unit's future cash flows, based on information currently available, however, these assumptions are inherently uncertain, require a high degree of estimation and judgment and are subject to change depending on the outcome of future events.
The following table presents a rollforward of net intangible assets by reportable segment.
| | | | | | | | | | | | | | | | | | | | | | | |
(dollars in thousands) | Underwriting(1) | | Markel Ventures | | Other(2) | | Total |
January 1, 2021 | $ | 442,639 | | | $ | 623,120 | | | $ | 716,959 | | | $ | 1,782,718 | |
Acquisitions | — | | | 203,879 | | | — | | | 203,879 | |
Amortization of intangible assets | (41,182) | | | (57,568) | | | (61,789) | | | (160,539) | |
| | | | | | | |
Foreign currency movements and other adjustments | (202) | | | (3,252) | | | (118) | | | (3,572) | |
December 31, 2021 | $ | 401,255 | | | $ | 766,179 | | | $ | 655,052 | | | $ | 1,822,486 | |
Acquisitions | — | | | 21,614 | | | — | | | 21,614 | |
Dispositions | — | | | — | | | (2,716) | | | (2,716) | |
Amortization of intangible assets | (38,533) | | | (79,043) | | | (61,202) | | | (178,778) | |
| | | | | | | |
Adjustments to preliminary purchase price allocation | — | | | 86,773 | | | — | | | 86,773 | |
Foreign currency movements and other adjustments | (400) | | | 774 | | | (2,289) | | | (1,915) | |
December 31, 2022 | $ | 362,322 | | | $ | 796,297 | | | $ | 588,845 | | | $ | 1,747,464 | |
(1) Amounts included in Underwriting reflect the intangible assets associated with the Company's underwriting segments, which are not allocated between the Insurance and Reinsurance segments.
(2) Amounts included in Other reflect the Company's operations that are not included in a reportable segment and are primarily related to the Company's program services and insurance-linked securities operations.
Amortization of intangible assets is estimated to be $174.0 million for 2023, $172.1 million for 2024, $165.6 million for 2025, $157.5 million for 2026 and $149.9 million for 2027. Indefinite-lived intangible assets were $92.4 million at both December 31, 2022 and 2021.
The following table presents the components of intangible assets.
| | | | | | | | | | | | | | | | | | | | | | | |
| December 31, |
| 2022 | | 2021 |
(dollars in thousands) | Gross Carrying Amount | | Accumulated Amortization | | Gross Carrying Amount | | Accumulated Amortization |
Customer relationships | $ | 1,425,330 | | | $ | (498,987) | | | $ | 1,379,739 | | | $ | (405,057) | |
Investment management agreements | 464,000 | | | (120,394) | | | 468,000 | | | (92,478) | |
Broker relationships | 204,972 | | | (117,386) | | | 206,855 | | | (109,210) | |
Trade names | 293,194 | | | (118,976) | | | 238,331 | | | (100,023) | |
Technology | 113,170 | | | (92,646) | | | 113,200 | | | (82,845) | |
Agent relationships | 92,000 | | | (34,756) | | | 92,000 | | | (28,622) | |
Insurance licenses | 74,333 | | | — | | | 74,333 | | | — | |
Renewal rights | 21,449 | | | (21,449) | | | 21,449 | | | (21,449) | |
Other | 148,326 | | | (84,716) | | | 145,695 | | | (77,432) | |
Total | $ | 2,836,774 | | | $ | (1,089,310) | | | $ | 2,739,602 | | | $ | (917,116) | |
9. Leases
The Company's leases primarily consist of operating leases for real estate and have remaining terms of up to 20 years. Total lease costs for operating leases were $126.3 million, $115.4 million and $94.4 million for the years ended December 31, 2022, 2021 and 2020, respectively.
The following table summarizes details for the Company's operating leases recorded on the consolidated balance sheets.
| | | | | | | | | | | |
| December 31, |
(dollars in thousands) | 2022 | | 2021 |
Right-of-use lease assets | $ | 526,704 | | | $ | 533,702 | |
Lease liabilities | $ | 554,394 | | | $ | 571,337 | |
Weighted average remaining lease term | 11.7 years | | 10.8 years |
Weighted average discount rate | 3.1 | % | | 3.0 | % |
The following table summarizes maturities of the Company's operating lease liabilities as of December 31, 2022, which reconciles to total operating lease liabilities included in other liabilities on the Company's consolidated balance sheet.
| | | | | |
Years Ending December 31, | (dollars in thousands) |
2023 | $ | 100,887 | |
2024 | 85,030 | |
2025 | 71,474 | |
2026 | 60,729 | |
2027 | 51,702 | |
2028 and thereafter | 291,290 | |
Total lease payments | 661,112 | |
Less imputed interest | (106,718) | |
Total operating lease liabilities | $ | 554,394 | |
10. Products, Services and Other Revenues
The amount of revenues from contracts with customers for the years ended December 31, 2022, 2021 and 2020 was $4.8 billion, $3.8 billion and $2.9 billion, respectively.
The following table presents revenues from contracts with customers by segment and type, all of which are included in products revenues and services and other revenues in the consolidated statements of income (loss) and comprehensive income (loss), along with a reconciliation to total products revenues and services and other revenues.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Years Ended December 31, |
| 2022 | | 2021 | | 2020 |
(dollars in thousands) | Markel Ventures | | Other | | Total | | Markel Ventures | | Other | | Total | | Markel Ventures | | Other | | Total |
Products | $ | 2,379,399 | | | $ | — | | | $ | 2,379,399 | | | $ | 1,668,448 | | | $ | — | | | $ | 1,668,448 | | | $ | 1,396,706 | | | $ | — | | | $ | 1,396,706 | |
Services | 2,265,413 | | | 43,875 | | | 2,309,288 | | | 1,863,706 | | | 134,850 | | | 1,998,556 | | | 1,295,734 | | | 116,476 | | | 1,412,210 | |
Investment management | — | | | 79,209 | | | 79,209 | | | — | | | 86,257 | | | 86,257 | | | — | | | 117,193 | | | 117,193 | |
Total revenues from contracts with customers | 4,644,812 | | | 123,084 | | | 4,767,896 | | | 3,532,154 | | | 221,107 | | | 3,753,261 | | | 2,692,440 | | | 233,669 | | | 2,926,109 | |
Program services and other fronting | — | | | 147,612 | | | 147,612 | | | — | | | 123,823 | | | 123,823 | | | — | | | 102,989 | | | 102,989 | |
Disposition gains | — | | | 225,828 | | | 225,828 | | | — | | | — | | | — | | | — | | | — | | | — | |
Other | 111,806 | | | (16,621) | | | 95,185 | | | 111,662 | | | 8,699 | | | 120,361 | | | 102,274 | | | (2,316) | | | 99,958 | |
Total | $ | 4,756,618 | | | $ | 479,903 | | | $ | 5,236,521 | | | $ | 3,643,816 | | | $ | 353,629 | | | $ | 3,997,445 | | | $ | 2,794,714 | | | $ | 334,342 | | | $ | 3,129,056 | |
Receivables from contracts with customers were $624.1 million and $626.1 million as of December 31, 2022 and 2021, respectively.
11. Unpaid Losses and Loss Adjustment Expenses
a) The following table presents a reconciliation of consolidated beginning and ending reserves for losses and loss adjustment expenses.
| | | | | | | | | | | | | | | | | |
| Years Ended December 31, |
(dollars in thousands) | 2022 | | 2021 | | 2020 |
Gross reserves for losses and loss adjustment expenses, beginning of year | $ | 18,178,894 | | | $ | 16,222,376 | | | $ | 14,728,676 | |
Reinsurance recoverables on unpaid losses, beginning of year | 6,876,317 | | | 5,736,659 | | | 5,253,415 | |
Net reserves for losses and loss adjustment expenses, beginning of year | 11,302,577 | | | 10,485,717 | | | 9,475,261 | |
Effect of foreign currency rate changes on beginning of year balance | (160,622) | | | (54,736) | | | 68,368 | |
Effect of adoption of ASC 326, Financial Instruments—Credit Losses | — | | | — | | | 3,849 | |
Adjusted net reserves for losses and loss adjustment expenses, beginning of year | 11,141,955 | | | 10,430,981 | | | 9,547,478 | |
Incurred losses and loss adjustment expenses: | | | | | |
Current accident year | 4,613,035 | | | 4,061,000 | | | 4,073,325 | |
Prior accident years | (167,446) | | | (478,930) | | | (606,414) | |
Total incurred losses and loss adjustment expenses | 4,445,589 | | | 3,582,070 | | | 3,466,911 | |
Payments: | | | | | |
Current accident year | 580,537 | | | 637,169 | | | 749,887 | |
Prior accident years | 2,396,446 | | | 2,066,290 | | | 1,779,980 | |
Total payments | 2,976,983 | | | 2,703,459 | | | 2,529,867 | |
Effect of foreign currency rate changes on current year activity | (5,468) | | | (4,253) | | | 1,195 | |
Net reserves for losses and loss adjustment expenses of Markel CATCo Re (see note 17) | 347,921 | | | — | | | — | |
Net reserves for losses and loss adjustment expenses of insurance companies sold | — | | | (2,762) | | | — | |
| | | | | |
Net reserves for losses and loss adjustment expenses, end of year | 12,953,014 | | | 11,302,577 | | | 10,485,717 | |
Reinsurance recoverables on unpaid losses, end of year | 7,994,884 | | | 6,876,317 | | | 5,736,659 | |
Gross reserves for losses and loss adjustment expenses, end of year | $ | 20,947,898 | | | $ | 18,178,894 | | | $ | 16,222,376 | |
Catastrophe Losses
In 2022, current accident year losses and loss adjustment expenses included $46.2 million of net losses and loss adjustment expenses attributed to Hurricane Ian, all of which were within the Company's Insurance segment. These losses and loss adjustment expenses were net of ceded losses of $115.3 million. The Company also had gross losses and loss adjustment expenses of $850.0 million within its program services and other fronting operations attributed to Hurricane Ian, all of which were ceded to third-party reinsurers managed through the Company's insurance-linked securities operations, which hold sufficient investor collateral to support the Company's related reinsurance recoverables. See note 18 for further details regarding related party transactions with third parties managed through the Company's insurance-linked securities operations.
In 2021, current accident year losses and loss adjustment expenses included $195.0 million of net losses and loss adjustment expenses from Winter Storm Uri, European Floods and Hurricane Ida (2021 Catastrophes). The net losses and loss adjustment expenses on the 2021 Catastrophes for the year ended December 31, 2021 were net of ceded losses of $221.7 million.
In 2020, current accident year losses and loss adjustment expenses included $172.2 million of net losses and loss adjustment expenses from Hurricanes Isaias, Laura, Sally, Delta and Zeta, as well as wildfires in the western U.S. and the derecho in Iowa (2020 Catastrophes). The net losses and loss adjustment expenses on the 2020 Catastrophes for the year ended December 31, 2020 were net of ceded losses of $125.7 million.
Russia-Ukraine Conflict
In 2022, current accident year losses and loss adjustment expenses also included $35.7 million of net losses and loss adjustment expenses attributed to the Russia-Ukraine conflict. These losses and loss adjustment expenses were net of ceded losses of $44.3 million. The gross and net losses and loss adjustment expenses attributed to the Russia-Ukraine conflict represent the Company's best estimates as of December 31, 2022 based upon information currently available. The Company's estimates for these losses are based on reported claims, detailed underwriting, actuarial and claims reviews of policies and in-force assumed reinsurance contracts for potential exposures, as well as analysis of ceded reinsurance contracts and analysis provided by the Company's brokers and claims counsel. These estimates include various assumptions about what areas within the affected regions have incurred losses, the nature and extent of such losses, which remain difficult to verify, as well as assumptions about coverage, liability and reinsurance. Given the significant levels of ceded reinsurance on certain of the impacted policies, a significant portion of any additional incurred losses may be ceded. While the Company believes the gross and net reserves for losses and loss adjustment expenses for the Russia-Ukraine conflict as of December 31, 2022 are adequate based on information currently available, the Company continues to closely monitor reported claims, ceded reinsurance contract attachment, government actions and areas impacted by the conflict and may adjust its estimates as new information becomes available.
COVID-19 Losses
In 2020, current accident year losses and loss adjustment expenses included $358.3 million of net losses and loss adjustment expenses attributed to the COVID-19 pandemic. These losses and loss adjustment expenses were net of ceded losses of $106.2 million. In 2021, the Company increased its estimate of net losses and loss adjustments expenses by $15.7 million. In 2022, the Company decreased its estimate of net losses and loss adjustment expenses by $5.4 million.
The gross and net losses and loss adjustment expenses attributed to COVID-19 represent the Company's best estimates as of December 31, 2022 based upon information currently available. The Company's estimates are based on reported claims and still include assumptions about coverage, liability and ceded reinsurance contract attachment, which, in some cases, remain subject to judicial review. While the Company believes the gross and net reserves for losses and loss adjustment expenses for COVID-19 as of December 31, 2022 are adequate based on information available at this time, the Company continues to closely monitor reported claims, claim settlements, ceded reinsurance contract settlements and judicial decisions and may adjust its estimates as new information becomes available.
b) Reserving Methodology
The Company uses a variety of techniques to establish the liabilities for unpaid losses and loss adjustment expenses based upon estimates of the ultimate amounts payable. The Company maintains reserves for specific claims incurred and reported (case reserves) and reserves for claims incurred but not reported (IBNR reserves), which include expected development on reported claims. The Company does not discount its reserves for losses and loss adjustment expenses to reflect estimated present value, except for reserves held for a run-off book of United Kingdom (U.K.) motor business. Additionally, reserves assumed in connection with an acquisition are recorded at fair value at the acquisition date. The fair value adjustment includes an adjustment to reflect the acquired reserves for losses and loss adjustment expenses at present value plus a risk premium, the net of which is amortized to losses and loss adjustment expenses within the consolidated statements of income.
As of any balance sheet date, all claims have not yet been reported, and some claims may not be reported for many years. As a result, the liability for unpaid losses and loss adjustment expenses includes significant estimates for incurred but not reported claims.
There is normally a time lag between when a loss event occurs and when it is reported to the Company. The actuarial methods that the Company uses to estimate losses have been designed to address the lag in loss reporting as well as the delay in obtaining information that would allow the Company to more accurately estimate future payments. There is also often a time lag between cedents establishing case reserves or re-estimating their reserves and notifying the Company of those new or revised case reserves. As a result, the reporting lag is more pronounced in reinsurance contracts than in the insurance contracts. On reinsurance transactions, the reporting lag will generally be 60 to 90 days after the end of a reporting period, but can be longer in some cases. There may also be a more pronounced reporting lag, as well as reliance on third-party claims handling practices and reserve estimates, on insurance contracts for which the Company is not the primary insurer and participates only in excess layers of loss. Based on the experience of the Company's actuaries and management, the Company selects loss development factors and trending techniques to mitigate the difficulties caused by reporting lags. At least annually, the Company evaluates its loss development factors and trending assumptions using its own loss data, as well as cedent-specific and industry data, and updates them as needed.
IBNR reserves are based on the estimated ultimate cost of settling claims, including the effects of inflation and other social and economic factors, using past experience adjusted for current trends and any other factors that would modify past experience. IBNR reserves are calculated by subtracting paid losses and loss adjustment expenses and case reserves from estimated ultimate losses and loss adjustment expenses. IBNR reserves were 70% of total unpaid losses and loss adjustment expenses at December 31, 2022 compared to 67% at December 31, 2021.
In establishing liabilities for unpaid losses and loss adjustment expenses, the Company's actuaries estimate an ultimate loss ratio, by accident year or underwriting year, for each product line with input from underwriting and claims personnel. For product lines in which loss reserves are established on an underwriting year basis, the Company has developed a methodology to convert from underwriting year to accident year for financial reporting purposes. In estimating an ultimate loss ratio for a particular line of business, the actuaries may use one or more actuarial reserving methods and select from these a single point estimate. To varying degrees, these methods include detailed statistical analysis of past claim reporting, settlement activity, claim frequency and severity, policyholder loss experience, industry loss experience and changes in market and economic conditions, policy forms and exposures. Greater judgment may be required when new product lines are introduced or when there have been changes in claims handling practices, as the statistical data available may be insufficient. Greater judgment also may be required for product lines that experience a low frequency of high severity claims, particularly when the Company is reliant on third party case reserve estimates and claims handling practices. These estimates also reflect implicit and explicit assumptions regarding the potential effects of external factors, including economic and social inflation, judicial decisions, changes in law, general economic conditions and recent trends in these factors. Management believes the process of evaluating past experience, adjusted for the effects of current developments and anticipated trends, is an appropriate basis for predicting future events.
Estimates for losses from widespread catastrophic events, such as hurricanes and earthquakes, as well as pandemics and wars, are based on claims received to date, industry loss estimates and output from both industry, broker and proprietary models, as well as analysis of the Company's ceded reinsurance contracts. The Company may also perform detailed policy and reinsurance contract level reviews. The availability of data from these procedures varies depending on the timing of the event relative to the point at which the Company develops its estimates. The Company also considers loss experience on historical events that may have similar characteristics to the underlying event and current market conditions, including the level of economic inflation. Due to the inherent uncertainty in estimating such losses, these estimates are subject to variability, which increases with the severity and complexity of the underlying event. As additional claims are reported and paid, and industry loss estimates are revised, the Company incorporates this new information into its analysis and adjusts its estimate of ultimate losses and loss adjustment expenses as appropriate. For example, both the gross and net losses on Hurricane Ian and the 2021 and 2020 Catastrophes, as of December 31, 2022 represent the Company's best estimates based upon information currently available. For Hurricane Ian, these estimates are still dependent on assumptions about coverage, liability and reinsurance. While the Company believes the gross and net reserves for these events as of December 31, 2022 are adequate, it continues to closely monitor reported claims and may adjust its estimates as new information becomes available.
Loss reserves are established at management's best estimate, which is developed using the actuarially calculated point estimate as the starting point. The actuarial point estimate represents the actuaries' estimate of the most likely amount that will ultimately be paid to settle the losses that have occurred at a particular point in time; however, there is inherent uncertainty in the point estimate as it is the expected value in a range of possible reserve estimates. In some cases, actuarial analyses, which are generally based on statistical analysis, cannot fully incorporate all of the subjective factors that affect development of losses. In other cases, management's perspective of these more subjective factors may differ from the actuarial perspective. Subjective factors influencing the development of management's best estimate include: the credibility and timeliness of claims and loss information received from cedents and other third parties, economic and social inflation, judicial decisions, changes in law, changes in underwriting or claims handling practices, general economic conditions, the risk of moral hazard and other current and developing trends within the insurance and reinsurance markets, including the effects of competition. For example, the Company's loss experience in recent years has reflected higher than anticipated levels of economic inflation, as well as the impacts of social inflation.
Inherent in the Company's reserving practices is the desire to establish loss reserves that are more likely redundant than deficient, and therefore, will ultimately prove to be adequate. This approach to establishing loss reserves typically results in loss reserves that exceed the calculated actuarial point estimate. However, following an acquisition of insurance operations, acquired reserves initially are recorded at fair value, and therefore the acquired loss reserves may be closer to the actuarial point estimate until the Company builds total loss reserves that are consistent with the Company's historic level of confidence. Management continually attempts to improve its loss estimation process by refining its ability to analyze loss development patterns, claim payments and other information, but uncertainty remains regarding the potential for adverse development of estimated ultimate liabilities.
The Company's ultimate liability may be greater or less than current reserves. Changes in the Company's estimated ultimate liability for loss reserves generally occur as a result of the emergence of unanticipated loss activity, the completion of specific actuarial or claims studies or changes in internal or external factors that impact the assumptions used to derive the Company's estimates. The Company closely monitors new information on reported claims and uses statistical analyses prepared by its actuaries to evaluate the adequacy of recorded reserves. Management exercises judgment when assessing the relative credibility of loss development trends.
Management currently believes the Company's gross and net reserves are adequate. However, there is no precise method for evaluating the impact of any significant factor on the adequacy of reserves, and actual results will differ from original estimates.
c) Prior Accident Year Loss Development
The following tables summarize, by segment, the product lines with the most significant changes in prior accident years loss reserves for the years ended December 31, 2022, 2021 and 2020, along with the corresponding accident years and the trends and factors that impacted management's best estimate of ultimate losses and loss adjustment expenses on underlying products in each of these product lines. The Company does not estimate losses at this level of aggregation as it offers a diverse portfolio of products and manages these products in logical groupings within each underwriting segment. As a result of the trends and factors described in the following tables, the Company's actuaries adjusted their estimates of the ultimate liability for unpaid losses and loss adjustment expenses. Additionally, for those product lines with favorable development on prior accident years loss reserves, management has now given more credibility to the favorable trends observed by the Company's actuaries and after also incorporating these favorable trends into its best estimate, reduced prior years loss reserves accordingly. The unfavorable claims and loss trends experienced on certain accident years within the Company's professional liability and general liability product lines in 2022 reflected broader market conditions, including the effects of economic and social inflation, as well as delays in court proceedings that began in 2020 and disrupted the development of the claims trend. These trends were most impactful on the 2018 and 2019 accident years for the professional liability product lines and the 2016 to 2019 accident years for the general liability product lines. Consistent with the Company's reserving philosophy, management is responding quickly to increase loss reserves following any indication of increased claims frequency or severity in excess of previous expectations.
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, 2022 |
(dollars in millions) | Loss Development | | Accident Years with Most Significant Development | | Trends and Factors Impacting Loss Estimates |
Insurance segment: | | | | | |
Professional liability | | | | | |
2018 and 2019 accident years | $ | 121.0 | | | 2018 and 2019 | | Unfavorable claims settlements and increased claim frequency and severity, primarily on directors and officers, errors and omissions and employment practices liability lines |
All other accident years | (91.1) | | | Several | | More favorable loss experience and lower loss severity than previously anticipated |
General liability | | | | | |
2016 to 2019 accident years | 61.6 | | | 2016 to 2019 | | Unfavorable claims settlements and increased claim frequency and severity, primarily on contractors and excess and umbrella lines |
All other accident years | (20.5) | | | Several | | Lower loss frequency and severity than previously anticipated |
Workers' compensation | (62.1) | | | 2016 to 2021 | | Lower loss severity than previously anticipated |
Programs | (48.3) | | | 2020 and 2021 | | Lower than expected frequency of claims |
Property | (48.1) | | | 2020 and 2021 | | Lower loss severity than originally anticipated as well as favorable development on COVID-19 |
Credit and surety | (31.7) | | | 2019 to 2021 | | Lower than expected frequency of claims |
Other products | (23.7) | | | | | |
Total Insurance | (142.9) | | | | | |
Reinsurance segment: | | | | | |
Property | (29.2) | | | 2017 to 2019 | | Favorable development on catastrophe events |
Credit and surety | (22.9) | | | Several | | Favorable commutations on mortgage insurance contracts |
Premium adjustments | 53.1 | | | 2020 and 2021 | | Recognition of additional exposures on prior accident years related to net favorable premium adjustments primarily on general liability, credit and surety and professional liability |
Other products | (27.1) | | | | | |
Total Reinsurance | (26.1) | | | | | |
Other underwriting | 1.6 | | | | | |
Total decrease | $ | (167.4) | | | | | |
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, 2021 |
(dollars in millions) | Loss Development | | Accident Years with Most Significant Development | | Trends and Factors Impacting Loss Estimates |
Insurance segment: | | | | | |
General liability | $ | (139.7) | | | Several | | Lower than expected frequency of claims and more favorable experience than originally anticipated across several sub-product lines |
Property | (96.5) | | | 2018 to 2020 | | Lower than expected frequency of large claims as well as favorable development on COVID-19 and catastrophe events |
Workers' compensation | (79.0) | | | Several | | Lower loss severity than originally anticipated |
Marine and energy | (60.0) | | | 2018 to 2020 | | Lower loss frequency and severity than originally anticipated |
Professional liability | (54.7) | | | Several | | Lower loss frequency and severity than originally anticipated |
Other products | (76.4) | | | | | |
Total Insurance | (506.3) | | | | | |
Reinsurance segment: | | | | | |
Property | 35.0 | | | 2020 | | Adverse development on COVID-19 and catastrophe events |
Professional liability | 29.2 | | | Several | | Recognition of additional exposures on prior accident years related to net favorable premium adjustments |
General liability | (19.2) | | | 2011, 2012, 2017 and 2020 | | Favorable development on COVID-19 and catastrophe events as well as lower than expected paid losses on reported claims |
Credit and surety | (16.6) | | | 2020 | | Favorable commutations on mortgage insurance contracts |
Other products | (8.5) | | | | | |
Total Reinsurance | 19.9 | | | | | |
Other underwriting | 6.6 | | | | | |
Total decrease | $ | (479.8) | | | | | |
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, 2020 |
(dollars in millions) | Loss Development | | Accident Years with Most Significant Development | | Trends and Factors Impacting Loss Estimates |
Insurance segment: | | | | | |
General liability | $ | (131.8) | | | Several | | More favorable claims experience than originally anticipated across several sub-product lines |
Professional liability | (128.9) | | | Several | | More favorable claims experience than originally anticipated across several sub-product lines |
Workers' compensation | (92.3) | | | 2017 to 2019 | | Lower loss severity than originally anticipated |
Marine and energy | (46.0) | | | 2016 to 2019 | | Lower than expected frequency of claims |
Other products | (155.6) | | | | | |
Total Insurance | (554.6) | | | | | |
Reinsurance segment: | | | | | |
Property | (68.4) | | | 2017 to 2019 | | Lower than expected severity of claims |
Public entity | 34.4 | | | 2016 to 2019 | | Higher than expected frequency and severity of claims |
Professional liability | 21.0 | | | 2016 to 2019 | | Recognition of additional exposures on prior accident years related to net favorable premium adjustments and higher than expected loss severity and claims frequency |
Other products | (38.8) | | | | | |
Total Reinsurance | (51.8) | | | | | |
| | | | | |
Total decrease | $ | (606.4) | | | | | |
d) Historic Loss Development
The following tables present undiscounted loss development information, by accident year, for the Company's Insurance and Reinsurance segments, including cumulative incurred and paid losses and allocated loss adjustment expenses, net of reinsurance, as well as the corresponding amount of IBNR reserves as of December 31, 2022. This level of disaggregation is consistent with how the Company analyzes loss reserves for both internal and external reporting purposes. The loss development information for the years ended December 31, 2013 through 2021 is presented as supplementary information. All amounts included in the following tables related to transactions denominated in a foreign currency have been translated into U.S. Dollars using the exchange rates in effect at December 31, 2022.
The difference between the segment loss development implied by the tables for the year ended December 31, 2022 and actual losses and loss adjustment expenses recognized on prior accident years for the Insurance and Reinsurance segments for the year ended December 31, 2022 is primarily attributed to the fact that amounts presented in these tables exclude amounts attributed to the 2012 and prior accident years. Favorable development on 2012 and prior accident years for the year ended December 31, 2022 totaled $50.8 million and $36.9 million for the Insurance and Reinsurance segments and reflects modest favorable development across many of the Company's product lines on accident years prior to 2013.
The remaining difference between the segment loss development implied by the tables for the year ended December 31, 2022 and actual losses and loss adjustment expenses on prior accident years is attributed to the fact that amounts presented in these tables exclude unallocated loss adjustment expenses and exclude amounts attributable to reserve discounting and fair value adjustments recorded in conjunction with acquisitions, as well as differences in the presentation of foreign currency movements, as previously described, none of which are material to the Insurance or Reinsurance segments.
The Insurance segment table that follows also includes claim frequency information, by accident year. The Company defines a claim as a single claim incident, per policy, which may include multiple claimants and multiple coverages on a single policy. Claim counts include claims closed without a payment as well as claims where the Company is monitoring to determine if an exposure exists, even if a reserve has not been established.
All of the business contained within the Company's Reinsurance segment represents treaty business that is assumed from other insurance or reinsurance companies, for which the Company does not have access to the underlying claim counts. Further, this business includes both quota share and excess of loss treaty reinsurance, through which only a portion of each reported claim results in losses to the Company. As such, the Company has excluded claim count information from the Reinsurance segment disclosures.
Insurance Segment
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(dollars in millions) | Ultimate Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance | | Total of Incurred-but-Not-Reported Liabilities, Net of Reinsurance | | Cumulative Number of Reported Claims |
Unaudited | | As of December 31, | | |
As of December 31, | | | |
Accident Year | 2013 | | 2014 | | 2015 | | 2016 | | 2017 | | 2018 | | 2019 | | 2020 | | 2021 | | 2022 | | December 31, 2022 |
2013 | $ | 1,724.9 | | | $ | 1,683.4 | | | $ | 1,514.7 | | | $ | 1,452.6 | | | $ | 1,406.2 | | | $ | 1,360.8 | | | $ | 1,315.6 | | | $ | 1,296.6 | | | $ | 1,292.8 | | | $ | 1,283.7 | | | $ | 43.3 | | | 91,000 | |
2014 | | | 1,850.8 | | | 1,680.7 | | | 1,613.0 | | | 1,556.8 | | | 1,508.6 | | | 1,487.4 | | | 1,455.2 | | | 1,457.7 | | | 1,438.2 | | | 52.8 | | | 86,000 | |
2015 | | | | | 1,769.1 | | | 1,695.0 | | | 1,571.9 | | | 1,517.8 | | | 1,487.2 | | | 1,455.2 | | | 1,451.2 | | | 1,442.2 | | | 65.9 | | | 89,000 | |
2016 | | | | | | | 1,858.0 | | | 1,854.2 | | | 1,756.3 | | | 1,703.9 | | | 1,677.1 | | | 1,669.8 | | | 1,682.3 | | | 86.9 | | | 101,000 | |
2017 | | | | | | | | | 2,312.1 | | | 2,179.6 | | | 2,061.0 | | | 2,018.2 | | | 2,004.7 | | | 2,023.7 | | | 103.5 | | | 139,000 | |
2018 | | | | | | | | | | | 2,432.4 | | | 2,325.5 | | | 2,099.9 | | | 2,061.6 | | | 2,153.7 | | | 194.9 | | | 193,000 | |
2019 | | | | | | | | | | | | | 2,556.6 | | | 2,299.1 | | | 2,244.4 | | | 2,295.5 | | | 335.6 | | | 228,000 | |
2020 | | | | | | | | | | | | | | | 3,083.4 | | | 2,974.7 | | | 2,914.7 | | | 1,042.6 | | | 179,000 | |
2021 | | | | | | | | | | | | | | | | | 3,085.7 | | | 2,909.0 | | | 1,483.0 | | | 137,000 | |
2022 | | | | | | | | | | | | | | | | | | | 4,097.4 | | | 2,791.3 | | | 121,000 | |
Total | | | | | | | | | | | | | | | | | | | $ | 22,240.4 | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance | | | | |
| Unaudited | | As of December 31, | | | | |
| As of December 31, | | | | | |
Accident Year | 2013 | | 2014 | | 2015 | | 2016 | | 2017 | | 2018 | | 2019 | | 2020 | | 2021 | | 2022 | | | | |
2013 | $ | 270.2 | | | $ | 568.9 | | | $ | 774.9 | | | $ | 943.8 | | | $ | 1,031.6 | | | $ | 1,092.9 | | | $ | 1,116.4 | | | $ | 1,150.2 | | | $ | 1,163.9 | | | $ | 1,178.2 | | | | | |
2014 | | | 329.6 | | | 652.6 | | | 886.6 | | | 1,052.9 | | | 1,157.3 | | | 1,240.4 | | | 1,288.8 | | | 1,308.8 | | | 1,339.9 | | | | | |
2015 | | | | | 321.0 | | | 660.7 | | | 870.9 | | | 1,034.0 | | | 1,142.1 | | | 1,230.9 | | | 1,260.6 | | | 1,293.0 | | | | | |
2016 | | | | | | | 370.3 | | | 747.4 | | | 975.4 | | | 1,160.0 | | | 1,288.3 | | | 1,351.9 | | | 1,427.5 | | | | | |
2017 | | | | | | | | | 436.0 | | | 983.9 | | | 1,275.6 | | | 1,511.1 | | | 1,620.1 | | | 1,741.0 | | | | | |
2018 | | | | | | | | | | | 492.2 | | | 1,019.3 | | | 1,346.9 | | | 1,498.3 | | | 1,674.8 | | | | | |
2019 | | | | | | | | | | | | | 523.9 | | | 1,082.4 | | | 1,261.4 | | | 1,574.1 | | | | | |
2020 | | | | | | | | | | | | | | | 807.8 | | | 1,150.9 | | | 1,518.1 | | | | | |
2021 | | | | | | | | | | | | | | | | | 474.3 | | | 988.5 | | | | | |
2022 | | | | | | | | | | | | | | | | | | | 834.4 | | | | | |
Total | | | | | | | | | | | | | | | | | | | $ | 13,569.5 | | | | | |
All outstanding liabilities for unpaid losses and loss adjustment expenses before 2013, net of reinsurance | | 237.4 | | | | | |
Total liabilities for unpaid losses and loss adjustment expenses, net of reinsurance | | $ | 8,908.3 | | | | | |
Variability in claim counts is primarily attributable to claim counts associated with a personal lines product with high claim frequency and low claim severity, which the Company did not write from 2014 to 2016. The related net incurred losses and allocated loss adjustment expenses are not material to the Insurance segment.
Reinsurance Segment
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Ultimate Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance | | Total of Incurred-but-Not-Reported Liabilities, Net of Reinsurance | | |
| Unaudited | | As of December 31, | | |
(dollars in millions) | As of December 31, | | | |
Accident Year | 2013 | | 2014 | | 2015 | | 2016 | | 2017 | | 2018 | | 2019 | | 2020 | | 2021 | | 2022 | | December 31, 2022 | | |
2013 | $ | 579.4 | | | $ | 571.8 | | | $ | 538.3 | | | $ | 525.4 | | | $ | 533.2 | | | $ | 496.1 | | | $ | 478.2 | | | $ | 480.0 | | | $ | 475.3 | | | $ | 476.9 | | | $ | 32.7 | | | |
2014 | | | 569.2 | | | 552.1 | | | 524.4 | | | 563.1 | | | 542.2 | | | 519.3 | | | 503.8 | | | 505.3 | | | 501.2 | | | 60.3 | | | |
2015 | | | | | 523.1 | | | 508.8 | | | 523.7 | | | 515.0 | | | 503.9 | | | 498.6 | | | 486.3 | | | 486.6 | | | 84.4 | | | |
2016 | | | | | | | 509.1 | | | 518.5 | | | 519.0 | | | 516.9 | | | 526.8 | | | 550.9 | | | 554.3 | | | 69.8 | | | |
2017 | | | | | | | | | 895.7 | | | 928.7 | | | 934.7 | | | 936.0 | | | 908.2 | | | 920.4 | | | 105.6 | | | |
2018 | | | | | | | | | | | 749.5 | | | 775.3 | | | 767.9 | | | 772.1 | | | 767.8 | | | 150.7 | | | |
2019 | | | | | | | | | | | | | 662.0 | | | 675.6 | | | 689.2 | | | 702.7 | | | 223.4 | | | |
2020 | | | | | | | | | | | | | | | 680.2 | | | 732.7 | | | 742.4 | | | 344.0 | | | |
2021 | | | | | | | | | | | | | | | | | 735.5 | | | 736.7 | | | 446.9 | | | |
2022 | | | | | | | | | | | | | | | | | | | 662.6 | | | 614.1 | | | |
Total | | | | | | | | | | | | | | | | | | | $ | 6,551.6 | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance | | | | |
| Unaudited | | As of December 31, | | | | |
| As of December 31, | | | | | |
Accident Year | 2013 | | 2014 | | 2015 | | 2016 | | 2017 | | 2018 | | 2019 | | 2020 | | 2021 | | 2022 | | | | |
2013 | $ | 70.6 | | | $ | 153.4 | | | $ | 205.5 | | | $ | 263.2 | | | $ | 295.6 | | | $ | 324.9 | | | $ | 343.3 | | | $ | 358.1 | | | $ | 369.5 | | | $ | 383.4 | | | | | |
2014 | | | 97.4 | | | 155.6 | | | 220.5 | | | 267.0 | | | 302.9 | | | 335.7 | | | 352.9 | | | 369.3 | | | 379.4 | | | | | |
2015 | | | | | 63.6 | | | 131.2 | | | 202.0 | | | 252.7 | | | 299.6 | | | 324.1 | | | 343.7 | | | 360.3 | | | | | |
2016 | | | | | | | 79.0 | | | 167.9 | | | 237.9 | | | 294.3 | | | 346.0 | | | 379.4 | | | 419.5 | | | | | |
2017 | | | | | | | | | 157.4 | | | 358.1 | | | 479.2 | | | 560.9 | | | 624.5 | | | 693.5 | | | | | |
2018 | | | | | | | | | | | 87.0 | | | 243.7 | | | 344.7 | | | 414.4 | | | 484.5 | | | | | |
2019 | | | | | | | | | | | | | 53.5 | | | 173.6 | | | 268.4 | | | 359.6 | | | | | |
2020 | | | | | | | | | | | | | | | 93.5 | | | 203.7 | | | 309.8 | | | | | |
2021 | | | | | | | | | | | | | | | | | 79.5 | | | 187.8 | | | | | |
2022 | | | | | | | | | | | | | | | | | | | 24.2 | | | | | |
Total | | | | | | | | | | | | | | | | | | | $ | 3,602.0 | | | | | |
All outstanding liabilities for unpaid losses and loss adjustment expenses before 2013, net of reinsurance | | 388.0 | | | | | |
Total liabilities for unpaid losses and loss adjustment expenses, net of reinsurance | | $ | 3,337.6 | | | | | |
The following table presents supplementary information about average historical claims duration as of December 31, 2022 based on the cumulative incurred and paid losses and allocated loss adjustment expenses presented above.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Average Annual Percentage Payout of Incurred Losses by Age (in Years), Net of Reinsurance |
Unaudited | 1 | | 2 | | 3 | | 4 | | 5 | | 6 | | 7 | | 8 | | 9 | | 10 |
Insurance | 22.0 | % | | 21.9 | % | | 13.8 | % | | 11.3 | % | | 7.1 | % | | 5.3 | % | | 2.9 | % | | 2.1 | % | | 1.6 | % | | 1.1 | % |
Reinsurance | 12.5 | % | | 16.4 | % | | 13.1 | % | | 10.4 | % | | 8.2 | % | | 6.3 | % | | 4.6 | % | | 3.3 | % | | 2.2 | % | | 2.9 | % |
The following table reconciles the net incurred and paid loss development tables to the liability for losses and loss adjustment expenses on the consolidated balance sheet.
| | | | | |
(dollars in thousands) | December 31, 2022 |
Net outstanding liabilities | |
Insurance segment | $ | 8,908,308 | |
Reinsurance segment | 3,337,587 | |
Other underwriting | 89,563 | |
Program services and other fronting | 9,982 | |
Markel CATCo Re (see note 17) | 347,921 | |
Liabilities for unpaid losses and loss adjustment expenses, net of reinsurance | 12,693,361 | |
| |
Reinsurance recoverable on unpaid losses | |
Insurance segment | 2,425,560 | |
Reinsurance segment | 277,854 | |
Other underwriting | 56,968 | |
Program services and other fronting | 5,234,502 | |
Total reinsurance recoverable on unpaid losses | 7,994,884 | |
| |
Unallocated loss adjustment expenses | 326,275 | |
Unamortized discount, net of acquisition fair value adjustments, included in unpaid losses and loss adjustment expenses | (66,622) | |
| 259,653 | |
Total gross liability for unpaid losses and loss adjustment expenses | $ | 20,947,898 | |
e) The Company has exposure to asbestos and environmental (A&E) claims primarily resulting from policies written by acquired insurance operations before their acquisition by the Company. The Company's exposure to A&E claims originated from umbrella, excess and commercial general liability insurance policies and assumed reinsurance contracts that were written on an occurrence basis from the 1970s to mid-1980s. Exposure also originated from claims-made policies that were designed to cover environmental risks provided that all other terms and conditions of the policy were met. A&E claims include property damage and clean-up costs related to pollution, as well as personal injury allegedly arising from exposure to hazardous materials. Development on A&E loss reserves is monitored separately from the Company's ongoing underwriting operations and is not included in a reportable segment.
At December 31, 2022, A&E reserves were $153.2 million and $54.5 million on a gross and net basis, respectively. At December 31, 2021, A&E reserves were $218.6 million and $66.2 million on a gross and net basis, respectively.
The Company's reserves for losses and loss adjustment expenses related to A&E exposures represent management's best estimate of ultimate settlement values based on statistical analysis of these reserves by the Company's actuaries. A&E exposures are subject to significant uncertainty due to potential loss severity and frequency resulting from the uncertain and unfavorable legal climate. A&E reserves could be subject to increases in the future, however, management believes the Company's gross and net A&E reserves at December 31, 2022 are adequate.
12. Reinsurance
In reinsurance and retrocession transactions, an insurance or reinsurance company transfers, or cedes, all or part of its exposure in return for a premium. The ceding of insurance does not legally discharge the Company from its primary liability for the full amount of the policies, and the Company will be required to pay the loss and bear collection risk if the reinsurer fails to meet its obligations under the reinsurance or retrocessional agreement. A credit risk exists with ceded reinsurance to the extent that any reinsurer is unable to meet the obligations assumed under the reinsurance or retrocessional contracts. Allowances are established for credit losses expected to be recognized over the life of the reinsurance recoverables.
Within its underwriting operations, the Company uses reinsurance and retrocessional reinsurance to manage its net retention on individual risks and overall exposure to losses while providing it with the ability to offer policies with sufficient limits to meet policyholder needs.
Within the Company's underwriting operations, at December 31, 2022 and 2021, balances recoverable from the ten largest reinsurers, by group, represented 62% and 63%, respectively, of reinsurance recoverables before considering reinsurance allowances and collateral. At December 31, 2022, the largest reinsurance balance was due from RenaissanceRe and represented 11% of reinsurance recoverables before considering reinsurance allowances and collateral.
Within its program services and other fronting businesses, the Company generally enters into quota share reinsurance agreements whereby the Company cedes to the capacity providers (reinsurers) substantially all of its gross liability under all policies issued by and on behalf of the Company by a general agent. However, there are certain programs that contain limits on the reinsurers' obligations to the Company that expose the Company to underwriting risk, including loss ratio caps, exclusions of the credit risk of producers and aggregate reinsurance limits that the Company believes are unlikely to be exceeded. The Company also remains exposed to the credit risk of the reinsurer, or the risk that one of its reinsurers becomes insolvent or otherwise unable or unwilling to pay policyholder claims. This credit risk is generally mitigated by either selecting well capitalized, highly rated authorized capacity providers or requiring that the capacity provider post substantial collateral to secure the reinsured risks, which, in some instances, exceeds the related reinsurance recoverable.
Within the Company's program services business, at December 31, 2022 and 2021, balances recoverable from the ten largest reinsurers, by group, represented 67% and 68%, respectively, of reinsurance recoverables before considering reinsurance allowances and collateral. At December 31, 2022, the largest reinsurance balance was due from Lloyd's of London (Lloyd's) and represented 13% of reinsurance recoverables before considering reinsurance allowances and collateral. All of the Company's other fronting business is conducted on behalf of its Nephila ILS operations; therefore, all of the reinsurance recoverables within these operations are attributable to entities it manages. See note 18.
The following tables summarize the effect of reinsurance and retrocessional reinsurance on premiums written and earned.
| | | | | | | | | | | | | | | | | | | | | | | |
| Year Ended December 31, 2022 |
(dollars in thousands) | Direct | | Assumed | | Ceded | | Net Premiums |
Underwriting: | | | | | | | |
Written | $ | 8,085,812 | | | $ | 1,761,726 | | | $ | (1,640,165) | | | $ | 8,207,373 | |
Earned | $ | 7,379,766 | | | $ | 1,589,920 | | | $ | (1,378,191) | | | $ | 7,591,495 | |
Program services and other fronting: | | | | | | | |
Written | 2,644,138 | | | 710,006 | | | (3,358,127) | | | (3,983) | |
Earned | 2,688,804 | | | 656,885 | | | (3,349,392) | | | (3,703) | |
Consolidated: | | | | | | | |
Written | $ | 10,729,950 | | | $ | 2,471,732 | | | $ | (4,998,292) | | | $ | 8,203,390 | |
Earned | $ | 10,068,570 | | | $ | 2,246,805 | | | $ | (4,727,583) | | | $ | 7,587,792 | |
| | | | | | | | | | | | | | | | | | | | | | | |
| Year Ended December 31, 2021 |
(dollars in thousands) | Direct | | Assumed | | Ceded | | Net Premiums |
Underwriting: | | | | | | | |
Written | $ | 6,863,229 | | | $ | 1,622,700 | | | $ | (1,360,763) | | | $ | 7,125,166 | |
Earned | $ | 6,275,078 | | | $ | 1,482,755 | | | $ | (1,250,392) | | | $ | 6,507,441 | |
Program services and other fronting: | | | | | | | |
Written | 2,644,955 | | | 307,798 | | | (2,958,188) | | | (5,435) | |
Earned | 2,453,990 | | | 261,591 | | | (2,719,993) | | | (4,412) | |
Consolidated: | | | | | | | |
Written | $ | 9,508,184 | | | $ | 1,930,498 | | | $ | (4,318,951) | | | $ | 7,119,731 | |
Earned | $ | 8,729,068 | | | $ | 1,744,346 | | | $ | (3,970,385) | | | $ | 6,503,029 | |
| | | | | | | | | | | | | | | | | | | | | | | |
| Year Ended December 31, 2020 |
(dollars in thousands) | Direct | | Assumed | | Ceded | | Net Premiums |
Underwriting: | | | | | | | |
Written | $ | 5,715,038 | | | $ | 1,444,967 | | | $ | (1,222,390) | | | $ | 5,937,615 | |
Earned | $ | 5,357,888 | | | $ | 1,394,239 | | | $ | (1,134,501) | | | $ | 5,617,626 | |
Program services and other fronting: | | | | | | | |
Written | 2,038,743 | | | 67,917 | | | (2,112,037) | | | (5,377) | |
Earned | 2,084,888 | | | 74,847 | | | (2,165,156) | | | (5,421) | |
Consolidated: | | | | | | | |
Written | $ | 7,753,781 | | | $ | 1,512,884 | | | $ | (3,334,427) | | | $ | 5,932,238 | |
Earned | $ | 7,442,776 | | | $ | 1,469,086 | | | $ | (3,299,657) | | | $ | 5,612,205 | |
Substantially all of the premiums written and earned in the Company's program services and other fronting operations for the years ended December 31, 2022, 2021 and 2020 were ceded. The percentage of consolidated ceded earned premiums to gross earned premiums was 38%, 38% and 37% for the years ended December 31, 2022, 2021 and 2020, respectively. The percentage of consolidated assumed earned premiums to net earned premiums was 30%, 27% and 26% for the years ended December 31, 2022, 2021 and 2020, respectively.
Substantially all of the incurred losses and loss adjustment expenses in the Company's program services and other fronting operations were ceded. These losses totaled $3.0 billion and $2.5 billion for the years ended December 31, 2022 and 2021, respectively.
The following table summarizes the effect of reinsurance and retrocessional reinsurance on losses and loss adjustment expenses in the Company's underwriting operations.
| | | | | | | | | | | | | | | | | |
| Years ended December 31, |
(dollars in thousands) | 2022 | | 2021 | | 2020 |
Gross losses and loss adjustment expenses | $ | 5,281,424 | | | $ | 4,477,752 | | | $ | 4,189,948 | |
Ceded losses and loss adjustment expenses | (834,648) | | | (893,230) | | | (722,619) | |
Net losses and loss adjustment expenses | $ | 4,446,776 | | | $ | 3,584,522 | | | $ | 3,467,329 | |
13. Life and Annuity Benefits
The following table presents reserves for life and annuity benefits.
| | | | | | | | | | | |
| December 31, |
(dollars in thousands) | 2022 | | 2021 |
Life | $ | 102,321 | | | $ | 113,797 | |
Annuities | 628,441 | | | 753,971 | |
Accident and health | 28,263 | | | 35,212 | |
Total | $ | 759,025 | | | $ | 902,980 | |
Life and annuity benefit reserves are compiled on a reinsurance contract-by-contract basis and are discounted using standard actuarial techniques and cash flow models. Since the development of the life and annuity reinsurance reserves is based upon cash flow projection models, the Company must make estimates and assumptions based on cedent experience, industry mortality tables, and expense and investment experience, including a provision for adverse deviation. The assumptions used to determine policy benefit reserves are generally locked-in for the life of the contract unless an unlocking event occurs. Loss recognition testing is performed to determine if existing policy benefit reserves, together with the present value of future gross premiums and expected investment income earned thereon, are adequate to cover the present value of future benefits, settlement and maintenance costs. If the existing policy benefit reserves are not sufficient, the locked-in assumptions are revised to current best estimate assumptions and a charge to earnings for life and annuity benefits is recognized at that time. See note 1(x) for information on changes to the accounting for life and annuity benefits beginning in 2023.
Life and annuity benefit reserves are also adjusted to the extent unrealized gains on the investments supporting the policy benefit reserves would result in a reserve deficiency if those gains were realized. As of December 31, 2021, the cumulative increase to life and annuity benefits attributable to unrealized gains on the underlying investment portfolio totaled $56.6 million, all of which reversed in 2022 as a result of an increase in the market yield on the investment securities supporting the policy benefit reserves. During 2021, the Company decreased life and annuity benefits by $63.0 million, reflecting an increase in the market yield on the investment securities supporting the policy benefit reserves, and increased the change in net unrealized holding gains included in other comprehensive loss by a corresponding amount. During 2020, the Company increased life and annuity benefits by $68.2 million, as a result of a decrease in the market yield on the investment securities supporting the policy benefit reserves, and decreased the change in net unrealized holding gains included in other comprehensive income by a corresponding amount.
Because of the assumptions and estimates used in establishing the Company's reserves for life and annuity benefit obligations and the long-term nature of these reinsurance contracts, the ultimate liability may be greater or less than the estimates. The average discount rate for the life and annuity benefit reserves was 2.3% as of December 31, 2022.
As of December 31, 2022, the largest life and annuity benefits reserve for a single contract was 33.7% of the total.
None of the annuities included in life and annuity benefits on the consolidated balance sheets are subject to discretionary withdrawal.
14. Senior Long-Term Debt and Other Debt
The following table summarizes the Company's senior long-term debt and other debt.
| | | | | | | | | | | |
| December 31, |
(dollars in thousands) | 2022 | | 2021 |
4.90% unsecured senior notes, due July 1, 2022, interest payable semi-annually, net of unamortized discount of $159 in 2021 | $ | — | | | $ | 349,815 | |
3.625% unsecured senior notes, due March 30, 2023, interest payable semi-annually, net of unamortized discount of $50 in 2022 and $251 in 2021 | 249,940 | | | 249,702 | |
3.50% unsecured senior notes, due November 1, 2027, interest payable semi-annually, net of unamortized discount of $1,161 in 2022 and $1,445 in 2021 | 298,502 | | | 298,136 | |
3.35% unsecured senior notes, due September 17, 2029, interest payable semi-annually, net of unamortized discount of $1,668 in 2022 and $1,916 in 2021 | 297,997 | | | 297,700 | |
7.35% unsecured senior notes, due August 15, 2034, interest payable semi-annually, net of unamortized discount of $800 in 2022 and $868 in 2021 | 129,004 | | | 128,932 | |
5.0% unsecured senior notes, due March 30, 2043, interest payable semi-annually, net of unamortized discount of $4,535 in 2022 and $4,759 in 2021 | 245,214 | | | 244,978 | |
5.0% unsecured senior notes, due April 5, 2046, interest payable semi-annually, net of unamortized discount of $5,689 in 2022 and $5,933 in 2021 | 493,585 | | | 493,310 | |
4.30% unsecured senior notes, due November 1, 2047, interest payable semi-annually, net of unamortized discount of $3,669 in 2022 and $3,821 in 2021 | 295,691 | | | 295,512 | |
5.0% unsecured senior notes, due May 20, 2049, interest payable semi-annually, net of unamortized discount of $6,900 in 2022 and $7,161 in 2021 | 591,927 | | | 591,621 | |
4.15% unsecured senior notes, due September 17, 2050, interest payable semi-annually, net of unamortized discount of $4,917 in 2022 and $5,095 in 2021 | 494,342 | | | 494,138 | |
3.45% unsecured senior notes, due May 7, 2052, interest payable semi-annually, net of unamortized discount of $8,182 in 2022 and $8,461 in 2021 | 590,689 | | | 590,378 | |
Other debt, at various interest rates ranging from 2.1% to 9.9% | 416,738 | | | 327,044 | |
Senior long-term debt and other debt | $ | 4,103,629 | | | $ | 4,361,266 | |
In May 2021, the Company issued $600 million of 3.45% unsecured senior notes due May 2052. Net proceeds to the Company were $591.4 million, before expenses. The Company used a portion of these proceeds to retire its 4.90% unsecured senior notes due July 1, 2022 ($350.0 million aggregate principal outstanding at December 31, 2021).
The Company's 7.35% unsecured senior notes due August 15, 2034 are not redeemable. The Company's other unsecured senior notes are redeemable by the Company at any time, subject to payment of a make-whole premium to the noteholders. None of the Company's senior long-term debt is subject to any sinking fund requirements.
The Company's other debt includes $414.1 million and $287.6 million associated with its Markel Ventures subsidiaries as of December 31, 2022 and 2021, respectively, which includes amounts outstanding on their respective credit facilities. The Markel Ventures debt is non-recourse to the holding company and generally is secured by the assets of those subsidiaries.
Various of the Company's Markel Ventures subsidiaries maintain revolving credit facilities or lines of credit, which provide up to $620 million of aggregate capacity for working capital and other general operational purposes. A portion of the capacity on certain of these credit facilities may be used as security for letters of credit and other obligations. At December 31, 2022 and 2021, $238.1 million and $94.3 million, respectively, of borrowings were outstanding under these credit facilities. As of December 31, 2022, one of the Company's Markel Ventures subsidiaries was not in compliance with certain financial covenants of its revolving credit facility, which had an outstanding balance of $97.9 million as of December 31, 2022. The subsidiary is working with its lenders and anticipates amending the facility. This event is not expected to have a material effect on the Company’s consolidated financial condition or results of operations. At December 31, 2022, all of the Company's other subsidiaries were in compliance with all covenants contained in their respective credit facilities.
The estimated fair value of the Company's senior long-term debt and other debt was $3.5 billion and $5.0 billion at December 31, 2022 and 2021, respectively.
The following table summarizes the future principal payments due at maturity on senior long-term debt and other debt as of December 31, 2022.
| | | | | |
Years Ending December 31, | (dollars in thousands) |
2023 | $ | 399,604 | |
2024 | 27,180 | |
2025 | 24,934 | |
2026 | 25,637 | |
2027 | 444,335 | |
2028 and thereafter | 3,226,317 | |
Total principal payments | $ | 4,148,007 | |
Net unamortized discount | (37,572) | |
Net unamortized debt issuance costs | (6,806) | |
Senior long-term debt and other debt | $ | 4,103,629 | |
The Company maintains a corporate revolving credit facility which provides up to $300 million of capacity for future acquisitions, investments and stock repurchases, and for other working capital and general corporate purposes. At the Company's discretion, up to $200 million of the total capacity may be used for letters of credit. The Company may increase the capacity of the facility by up to $200 million subject to obtaining commitments for the increase and certain other terms and conditions. The Company pays interest on balances outstanding under the facility and a utilization fee for letters of credit issued under the facility. The Company also pays a commitment fee (0.20% at December 31, 2022) on the unused portion of the facility based on the Company's leverage ratio as calculated under the credit agreement. The credit agreement includes financial covenants that require that the Company not exceed a maximum leverage ratio and maintain a minimum amount of consolidated net worth, as well as other customary covenants and events of default. At December 31, 2022 and 2021, the Company had no borrowings outstanding under this revolving credit facility. This facility expires in April 2024. As of December 31, 2022, the Company was in compliance with all covenants contained in its corporate revolving credit facility.
To the extent that the Company or any of its subsidiaries are not in compliance with the covenants under their respective credit facilities, access to such credit facilities could be restricted.
The Company paid $197.3 million, $178.6 million and $178.2 million in interest on its senior long-term debt and other debt during the years ended December 31, 2022, 2021 and 2020, respectively.
15. Income Taxes
Income (loss) before income taxes includes the following components, based on country of domicile.
| | | | | | | | | | | | | | | | | |
| Years Ended December 31, |
(dollars in thousands) | 2022 | | 2021 | | 2020 |
U.S. operations | $ | (109,311) | | | $ | 2,263,748 | | | $ | 1,003,714 | |
Foreign operations | (39,528) | | | 868,445 | | | (3,265) | |
Income (loss) before income taxes | $ | (148,839) | | | $ | 3,132,193 | | | $ | 1,000,449 | |
Income tax expense (benefit) includes the following components, based on the taxing authority to which taxes are paid. The Company's most significant U.K. and Bermuda subsidiaries have elected to be taxed as domestic corporations for U.S. tax purposes. U.S. income tax also includes state income tax expense, which is not material to the consolidated financial statements.
| | | | | | | | | | | | | | | | | |
| Years Ended December 31, |
(dollars in thousands) | 2022 | | 2021 | | 2020 |
Current: | | | | | |
U.S. income tax | $ | 222,074 | | | $ | 200,742 | | | $ | 182,046 | |
Foreign income tax | 12,042 | | | 29,811 | | | (10,631) | |
Total current tax expense | 234,116 | | | 230,553 | | | 171,415 | |
Deferred: | | | | | |
U.S. income tax | (300,850) | | | 438,240 | | | (557) | |
Foreign income tax | 19,098 | | | 15,665 | | | (2,176) | |
Total deferred tax expense (benefit) | (281,752) | | | 453,905 | | | (2,733) | |
Income tax expense (benefit) | $ | (47,636) | | | $ | 684,458 | | | $ | 168,682 | |
For foreign subsidiaries that the Company has not elected to treat as domestic corporations for U.S. tax purposes, the Company is subject to the U.S. Global Intangible Low Taxes Income (GILTI) tax. The Company recognizes the impact of the GILTI tax as incurred, and for the years ended December 31, 2022, 2021 and 2020, GILTI tax was not material to the consolidated financial statements. Additionally, U.S. income taxes have not been recognized on any undistributed earnings of the Company's foreign subsidiaries that are considered indefinitely reinvested, the amount of which is not material to the consolidated financial statements.
The Company made net income tax payments of $251.5 million, $204.9 million and $241.7 million in 2022, 2021 and 2020, respectively. Income taxes payable were $2.2 million and $31.3 million at December 31, 2022 and 2021, respectively, and were included in other liabilities on the consolidated balance sheets. Income taxes receivable were $9.9 million and $18.9 million at December 31, 2022 and 2021, respectively, and were included in other assets on the consolidated balance sheets.
The following table presents a reconciliation of the Company's income taxes using the U.S. corporate income tax rate to the Company's income tax expense (benefit).
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| Years Ended December 31, |
(dollars in thousands) | 2022 | | 2021 | | 2020 |
U.S. corporate tax rate | $ | (31,256) | | 21.0 | % | | $ | 657,760 | | 21.0 | % | | $ | 210,093 | | 21.0 | % |
Increase (decrease) resulting from: | | | | | | | | |
Tax-exempt investment income | (16,063) | | 10.8 | | (16,109) | | (0.5) | | (16,415) | | (1.6) |
Foreign operations | 5,335 | | (3.6) | | 14,443 | | 0.5 | | 6,500 | | 0.6 |
Impairment of goodwill | 16,800 | | (11.3) | | — | | 0.0 | | — | | 0.0 |
Markel CATCo Re income not subject to tax | (18,871) | | 12.7 | | — | | 0.0 | | — | | 0.0 |
Nondeductible (deductible) losses on certain foreign investments | (160) | | 0.1 | | 1,240 | | 0.0 | | (38,666) | | (3.9) |
Other | (3,421) | | 2.3 | | 27,124 | | 0.9 | | 7,170 | | 0.7 |
Income tax expense (benefit) | $ | (47,636) | | 32.0 | % | | $ | 684,458 | | 21.9 | % | | $ | 168,682 | | 16.8 | % |
The following table presents the components of domestic and foreign deferred tax assets and liabilities.
| | | | | | | | | | | |
| December 31, |
(dollars in thousands) | 2022 | | 2021 |
Assets: | | | |
Unpaid losses and loss adjustment expenses | $ | 170,518 | | | $ | 186,759 | |
Unearned premiums | 161,243 | | | 139,350 | |
Lease liabilities | 132,735 | | | 135,795 | |
Life and annuity benefits | 54,893 | | | 78,777 | |
Accrued incentive compensation | 39,469 | | | 50,806 | |
Net operating loss carryforwards | 25,305 | | | 47,510 | |
Tax credit carryforwards | 18,264 | | | 21,734 | |
Other differences between financial reporting and tax bases | 65,250 | | | 66,951 | |
Total gross deferred tax assets | 667,677 | | | 727,682 | |
Less valuation allowance | (16,943) | | | (23,352) | |
Total gross deferred tax assets, net of allowance | 650,734 | | | 704,330 | |
Liabilities: | | | |
Investments | 761,421 | | | 1,401,871 | |
Goodwill and other intangible assets | 180,186 | | | 185,195 | |
Deferred policy acquisition costs | 161,220 | | | 146,601 | |
Property, plant and equipment | 144,259 | | | 126,846 | |
Right-of-use lease assets | 127,398 | | | 127,313 | |
Other differences between financial reporting and tax bases | 113,065 | | | 129,866 | |
Total gross deferred tax liabilities | 1,487,549 | | | 2,117,692 | |
Net deferred tax liability | $ | 836,815 | | | $ | 1,413,362 | |
Deferred tax assets and liabilities are recorded on the consolidated balance sheets on a net basis by taxing jurisdiction. As of December 31, 2022 and 2021, the Company's consolidated balance sheets included net deferred tax liabilities of $874.0 million and $1.4 billion, respectively, in other liabilities and net deferred tax assets of $37.2 million and $18.4 million, respectively, in other assets.
At December 31, 2022, the Company had tax credit carryforwards of $18.3 million, substantially all of which related to foreign tax credits to be used against U.S. income tax. The Company expects to utilize all tax credit carryforwards before expiration. The earliest any of these credits will expire is 2031.
At December 31, 2022, the Company also had net operating losses of $82.0 million that can be used to offset future taxable income, most of which is attributable to losses of certain branch operations in Europe incurred in their local jurisdictions. The Company's ability to use the majority of these losses is not subject to expiration. As described below, the deferred tax assets related to losses at certain of the Company's subsidiaries and branches are offset by valuation allowances.
At December 31, 2022, the Company had total gross deferred tax assets of $667.7 million. The Company has a valuation allowance of $16.9 million to offset gross deferred tax assets primarily attributable to cumulative net operating losses at certain of the Company's subsidiaries and branches. The Company believes that it is more likely than not that it will realize the remaining $650.7 million of gross deferred tax assets through generating taxable income or the reversal of existing temporary differences attributable to the gross deferred tax liabilities. Additionally, the Company's net deferred tax liability for investments includes deferred tax assets attributed to its unrealized losses on fixed maturity securities. The Company has the ability and intent to execute a tax planning strategy such that it is more likely than not that all of these deferred tax assets will be realized.
At December 31, 2022, the Company did not have any material unrecognized tax benefits. The Company does not anticipate any changes in unrecognized tax benefits during 2023 that would have a material impact on the Company's income tax provision.
The Company is subject to income tax in the U.S. and in foreign jurisdictions. The Internal Revenue Service is currently examining the Company's 2017 U.S. federal income tax return. The Company believes its income tax liabilities are adequate as of December 31, 2022, however, these liabilities could be adjusted as a result of this examination. With few exceptions, the Company is no longer subject to income tax examination by tax authorities for years ended before January 1, 2017.
16. Employee Benefit Plans
a) The Company maintains defined contribution plans for employees of its U.S. insurance operations in accordance with Section 401(k) of the U.S. Internal Revenue Code of 1986. Employees of the Company's Markel Ventures subsidiaries are provided post-retirement benefits under separate defined contribution plans. The Company also provides various defined contribution plans for employees of its international insurance operations, which are in line with local market terms and conditions of employment. Expenses relating to the Company's defined contribution plans were $57.9 million, $52.7 million and $48.6 million in 2022, 2021 and 2020, respectively.
b) The Terra Nova Pension Plan is a defined benefit plan that covers certain employees in the Company's international insurance operations who meet the eligibility conditions set out in the plan. The plan has been closed to new participants since 2001, and employees have not accrued benefits for future service in the plan since April 2012. The projected benefit obligations of the Terra Nova Pension Plan as of December 31, 2022 and 2021 were $108.5 million and $210.2 million, respectively, and the related fair value of plan assets was $171.7 million and $243.6 million, respectively. The corresponding net asset for pension benefits, also referred to as the funded status of the plan, at December 31, 2022 and 2021 was included in other assets on the Company's consolidated balance sheets.
17. Variable Interest Entities
MCIM, a wholly-owned consolidated subsidiary of the Company, is an insurance-linked securities investment fund manager and reinsurance manager headquartered in Bermuda. Results attributable to MCIM are not included in a reportable segment.
MCIM serves as the insurance manager for Markel CATCo Re Ltd. (Markel CATCo Re), a Bermuda Class 3 reinsurance company, and as the investment manager for Markel CATCo Reinsurance Fund Ltd., a Bermuda exempted mutual fund company comprised of multiple segregated accounts (Markel CATCo Funds). Voting shares in Markel CATCo Reinsurance Fund Ltd. and Markel CATCo Re are held by MCIM, which has the power to direct the activities that most significantly impact the economic performance of these entities. The Markel CATCo Funds issued multiple classes of nonvoting, redeemable preference shares to investors, and the Markel CATCo Funds are primarily invested in nonvoting preference shares of Markel CATCo Re. The underwriting results of Markel CATCo Re are attributed to investors through its nonvoting preference shares. Both Markel CATCo Re and the Markel CATCo Funds were placed into run-off in July 2019.
In March 2022, the Company completed a buy-out transaction with Markel CATCo Re and the Markel CATCo Funds that provided for an accelerated return of all remaining capital to investors in the Markel CATCo Funds. Under the terms of the transaction, the Company provided cash funding of $45.1 million to purchase substantially all of the Markel CATCo Funds' interests in Markel CATCo Re. See note 21 for further details regarding the terms of the buy-out transaction. As part of the transaction, substantially all of the preference shares held by investors in the Markel CATCo Funds were redeemed, including preference shares previously held by the Company. See note 5 for details regarding the Company's investment in the Markel CATCo Funds.
During June 2022, the Company received a return of $24.9 million of the capital it provided in March 2022 and the related preference shares were redeemed. As of December 31, 2022, the Company's investment in the remaining preference shares of Markel CATCo Re totaled $20.1 million, which comprised 23% of the equity of Markel CATCo Re. Through that investment, the Company has exposure to adverse loss development on reinsurance contracts previously written by Markel CATCo Re for loss events that occurred from 2014 to 2020. If loss reserves held by Markel CATCo Re are sufficient to settle claims on the remaining open contracts, the Company will receive a full return of the remaining $20.1 million in capital. Favorable development on loss reserves held by Markel CATCo Re, less operating expenses, will be distributed to the Markel CATCo Funds, and ultimately to investors in the Markel CATCo Funds.
Markel CATCo Re is considered a VIE, as the equity at risk does not have the right to receive residual returns that exceed the capital provided by the Company in the buy-out transaction. As a result of the preference shares acquired by the Company in the buy-out transaction, and the voting shares held by its consolidated subsidiary, MCIM, the Company consolidates Markel CATCo Re as its primary beneficiary. Results attributed to the run-off of Markel CATCo Re are reported with the Company's other ILS operations, within services and other revenues and expenses, and are not included in a reportable segment. For the
year ended December 31, 2022, there was $89.9 million of favorable loss reserve development on the run-off of reinsurance contracts written by Markel CATCo Re, all of which was included in services and other expenses and attributable to noncontrolling interests.
The Company's consolidated balance sheet includes the following amounts attributable to Markel CATCo Re.
| | | | | |
(dollars in thousands) | December 31, 2022 |
Assets | |
Cash and cash equivalents | $ | 104,443 | |
Restricted cash and cash equivalents | 317,577 | |
Other assets and receivables due from cedents | 41,357 | |
Total Assets | $ | 463,377 | |
| |
Liabilities and Equity | |
Unpaid losses and loss adjustment expenses | $ | 347,921 | |
Other liabilities | 26,717 | |
Total Liabilities | 374,638 | |
Shareholders' equity | 21,139 | |
Noncontrolling interests | 67,600 | |
Total Equity | 88,739 | |
Total Liabilities and Equity | $ | 463,377 | |
In connection with the buy-out transaction, the Company also entered into a tail risk cover with Markel CATCo Re. Through this contract, the Company has $142.7 million of uncollateralized exposure to adverse development on loss reserves held by Markel CATCo Re for loss exposures in excess of limits that the Company believes are unlikely to be exceeded.
18. Related Party Transactions
The Company engages in certain related party transactions in the normal course of business at arm's length.
Insurance-Linked Securities
Within the Company's insurance-linked securities operations, the Company provides investment and insurance management services through Nephila Holdings Ltd. (together with its subsidiaries, Nephila). Nephila serves as the investment manager to several Bermuda based private funds (the Nephila Funds). To provide access for the Nephila Funds to a variety of insurance-linked securities in the property catastrophe, climate and specialty markets, Nephila also acts as an insurance manager to certain Bermuda Class 3 and 3A reinsurance companies, Lloyd's Syndicate 2357 and Lloyd's Syndicate 2358 (collectively, the Nephila Reinsurers). Nephila receives management fees for investment and insurance management services provided through its insurance-linked securities operations primarily based on the net asset value of the accounts managed, and, for certain funds, incentive fees based on their annual performance. Prior to the disposition of Velocity in February 2022, Nephila also provided managing general agent services to the Nephila Reinsurers in exchange for commissions. For the years ended December 31, 2022, 2021 and 2020, total revenues attributed to unconsolidated entities managed by Nephila were $79.5 million, $141.9 million and $152.0 million, respectively.
Through the Company's program services and other fronting operations, as well as its underwriting operations, the Company has programs with Nephila through which the Company writes insurance policies that are either partially or fully ceded to Nephila Reinsurers. Through the Company's program services and other fronting platforms, Nephila utilizes certain of the Company's licensed insurance companies to write U.S. catastrophe exposed property risk that is then ceded to Nephila Reinsurers. For the years ended December 31, 2022, 2021 and 2020, gross premiums written through the Company's program services and other fronting platforms on behalf of Nephila were $1.0 billion, $689.2 million and $412.4 million, respectively, all of which were ceded to Nephila Reinsurers. Through the Company's insurance underwriting operations, the Company has a quota share agreement with Nephila through which it cedes a portion of its property business to Nephila Reinsurers. For the years ended December 31, 2022, 2021 and 2020, the Company's underwriting operations ceded premiums of $65.6 million, $55.0 million and $47.6 million, respectively, to Nephila Reinsurers as part of its quota share agreement.
As of December 31, 2022 and 2021, reinsurance recoverables on the consolidated balance sheets included $1.4 billion and $807.0 million, respectively, due from Nephila Reinsurers. Under its programs with Nephila Reinsurers, the Company bears underwriting risk for annual aggregate agreement year losses in excess of a limit the Company believes is unlikely to be exceeded. To the extent losses under these programs exceed the prescribed limits, the Company is obligated to pay such losses to the cedents without recourse to the Nephila Reinsurers. While the Company believes losses under these programs are unlikely, those losses, if incurred, could be material to the Company's consolidated results of operations and financial condition.
The Company has also entered into other assumed and ceded reinsurance transactions with the Nephila Reinsurers in the normal course of business, which are not material to the Company's consolidated financial statements.
Hagerty
The Company holds a minority ownership interest in Hagerty, which operates primarily as a managing general agent and also includes Hagerty Reinsurance Limited (Hagerty Re), a Bermuda Class 3 reinsurance company. Through the Company's underwriting operations, the Company underwrites insurance for Hagerty, and a portion of this insurance is ceded to Hagerty Re. For the years ended December 31, 2022, 2021 and 2020, the Company's gross written premiums attributable to Hagerty were $689.7 million, $596.9 million and $506.7 million, respectively, of which $456.6 million, $338.9 million and $239.3 million, respectively, were ceded to Hagerty Re. As of December 31, 2022 and 2021, reinsurance recoverables on the consolidated balance sheets included $159.7 million and $95.6 million, respectively, due from Hagerty Re.
19. Shareholders' Equity
a) The Company has 50,000,000 shares of no par value common stock authorized. The following table presents a rollforward of changes in common shares issued and outstanding.
| | | | | | | | | | | |
| Years Ended December 31, |
(in thousands) | 2022 | | 2021 |
Issued and outstanding common shares, beginning of year | 13,632 | | | 13,783 | |
Issuance of common shares | 24 | | | 18 | |
Repurchase of common shares | (233) | | | (169) | |
Issued and outstanding common shares, end of year | 13,423 | | | 13,632 | |
b) The Company also has 10,000,000 shares of no par value preferred stock authorized, of which 600,000 shares were issued and outstanding at December 31, 2022 and 2021. The Company has the option to redeem the preferred shares:
•in whole but not in part, at any time, within 90 days after the occurrence of a "rating agency event," at $1,020 per preferred share, plus accrued and unpaid dividends,
•in whole but not in part, at any time, within 90 days after the occurrence of a "regulatory capital event" at $1,000 per preferred share, plus accrued and unpaid dividends, or
•in whole or in part, on June 1, 2025, or every fifth anniversary of that date, at $1,000 per preferred share, plus accrued and unpaid dividends.
A "rating agency event" means that any nationally recognized statistical rating organization that publishes a rating for the Company amends, clarifies or changes the criteria it uses to assign equity credit to securities like the preferred shares, which results in shortening the length of time that the preferred shares are assigned a particular level of equity credit or in the lowering of the equity credit assigned to the preferred shares.
A "regulatory capital event" means that the Company becomes subject to capital adequacy supervision by a capital regulator and determines that, under such capital adequacy guidelines, the liquidation preference amount of the preferred shares would not qualify as capital.
The preferred shares rank senior to the Company's common stock with respect to the payment of dividends and liquidation rights. Holders of the preferred shares are entitled to receive non-cumulative cash dividends, when, as and if declared by the Board of Directors, from the original issue date, semi-annually in arrears on the first day of June and December of each year. The Company accrues dividends when they are declared by the Board of Directors. To the extent declared, these dividends will accrue, on the liquidation preference of $1,000 per share, at a fixed annual rate of 6.00% from the original issue date to
June 1, 2025. After June 1, 2025, the dividend rate will reset every five years and accrue at an annual rate equal to the five-year U.S. Treasury Rate as of two business days prior to the reset date, plus 5.662%. Dividends will not be cumulative and will not be mandatory. Accordingly, if dividends are not declared for any dividend period, then dividends for that dividend period will not accrue and will not be payable.
For both years ended December 31, 2022 and 2021, the Company declared and paid dividends on preferred shares of $36.0 million, or $60.00 per share.
c) The following table presents net income (loss) per common share and diluted net income (loss) per common share.
| | | | | | | | | | | | | | | | | |
| Years Ended December 31, |
(in thousands, except per share amounts) | 2022 | | 2021 | | 2020 |
Net income (loss) to common shareholders | $ | (250,123) | | | $ | 2,389,003 | | | $ | 797,630 | |
Adjustment of redeemable noncontrolling interests | (69,896) | | | 46,874 | | | (28,705) | |
Adjusted net income (loss) to common shareholders | $ | (320,019) | | | $ | 2,435,877 | | | $ | 768,925 | |
| | | | | |
Basic common shares outstanding | 13,580 | | | 13,768 | | | 13,811 | |
| | | | | |
Dilutive potential common shares from restricted stock units and restricted stock (1) (2) | — | | | 32 | | | 12 | |
Diluted common shares outstanding | 13,580 | | | 13,800 | | | 13,823 | |
Basic net income (loss) per common share | $ | (23.57) | | | $ | 176.92 | | | $ | 55.67 | |
Diluted net income (loss) per common share (1) (2) | $ | (23.57) | | | $ | 176.51 | | | $ | 55.63 | |
(1) The Company has issued grants and awards of restricted stock units to employees as performance, retention or hiring incentives, as well as awards of restricted stock to non-employee directors, under its equity incentive compensation plan. At December 31, 2022, there were 116,431 shares available for future awards under the Company's equity incentive compensation plan.
(2) The impact of 33 thousand shares from restricted stock units and restricted stock was excluded from the computation of diluted net loss per common share for the year ended December 31, 2022 because the effect would have been anti-dilutive.
20. Other Comprehensive Income
Other comprehensive income includes changes in net unrealized gains (losses) on available-for-sale investments, which is comprised of net holding gains (losses) arising during the period, changes in unrealized other-than-temporary impairment losses, if any, and reclassification adjustments for net realized gains included in net income. Other comprehensive income also includes changes in foreign currency translation adjustments and changes in net actuarial pension loss. The following table presents the change in accumulated other comprehensive income (loss) by component, net of noncontrolling interests.
| | | | | | | | | | | | | | | | | | | | | | | |
(dollars in thousands) | Unrealized Gains (Losses) on Available-for-Sale Investments | | Foreign Currency | | Net Actuarial Pension Loss | | Accumulated other comprehensive income (loss) |
December 31, 2019 | $ | 346,037 | | | $ | (86,249) | | | $ | (51,016) | | | $ | 208,772 | |
Total other comprehensive income (loss) before income taxes | 442,089 | | | 29,829 | | | (8,849) | | | 463,069 | |
Income tax (expense) benefit | (89,316) | | | — | | | 1,851 | | | (87,465) | |
Total other comprehensive income (loss) | 352,773 | | | 29,829 | | | (6,998) | | | 375,604 | |
December 31, 2020 | $ | 698,810 | | | $ | (56,420) | | | $ | (58,014) | | | $ | 584,376 | |
Total other comprehensive income (loss) before income taxes | (450,096) | | | (2,091) | | | 10,663 | | | (441,524) | |
Income tax (expense) benefit | 95,158 | | | 1,880 | | | (2,273) | | | 94,765 | |
Total other comprehensive income (loss) | (354,938) | | | (211) | | | 8,390 | | | (346,759) | |
December 31, 2021 | $ | 343,872 | | | $ | (56,631) | | | $ | (49,624) | | | $ | 237,617 | |
Total other comprehensive income (loss) before income taxes | (1,407,316) | | | (9,677) | | | 31,222 | | | (1,385,771) | |
Income tax (expense) benefit | 297,168 | | | 401 | | | (6,492) | | | 291,077 | |
Total other comprehensive income (loss) | (1,110,148) | | | (9,276) | | | 24,730 | | | (1,094,694) | |
December 31, 2022 | $ | (766,276) | | | $ | (65,907) | | | $ | (24,894) | | | $ | (857,077) | |
21. Commitments and Contingencies
a) In March 2022, the Company completed a buy-out transaction with Markel CATCo Re and the Markel CATCo Funds, which are currently in run-off, that provided for an accelerated return of all remaining capital to investors in the Markel CATCo Funds. Under the terms of the transaction, the Company provided cash funding of $45.1 million to purchase substantially all of the Markel CATCo Funds' investments in Markel CATCo Re and also provided tail risk cover of $142.7 million to Markel CATCo Re to allow for the release of collateral to investors. In order to complete the transaction, the Company also made $101.9 million in additional payments, net of insurance proceeds, to or for the benefit of investors, which were recognized as an expense to the Company and included in services and other expenses for the year ended December 31, 2022. In conjunction with the buy-out transaction, all investors holding securities in the Markel CATCo Funds, the Markel CATCo Group Companies (MCIM, the Markel CATCo Funds and Markel CATCo Re), Markel Corporation and each of their related parties, among others, granted mutual releases of all claims related to the transaction, the Markel CATCo Group Companies' businesses and the investors' investments in the Funds, including any pending litigation. See note 17 for further details about the Company's Markel CATCo operations and the buy-out transaction.
b) Contingencies arise in the normal course of the Company's operations and are not expected to have a material impact on the Company's financial condition or results of operations.
22. Statutory Financial Information
a) The following table summarizes statutory capital and surplus for the Company's insurance subsidiaries.
| | | | | | | | | | | |
| December 31, |
(dollars in thousands) | 2022 | | 2021 |
United States | $ | 5,236,793 | | | $ | 4,493,310 | |
United Kingdom | $ | 749,495 | | | $ | 736,575 | |
Bermuda | $ | 1,895,132 | | | $ | 2,106,606 | |
Germany | $ | 125,194 | | | $ | 95,693 | |
As of December 31, 2022, the Company's actual statutory capital and surplus significantly exceeded the regulatory requirements. As a result, the amount of statutory capital and surplus necessary to satisfy regulatory requirements is not significant in relation to actual statutory capital and surplus.
The following table summarizes statutory net income (loss) for the Company's insurance subsidiaries.
| | | | | | | | | | | | | | | | | |
| Years Ended December 31, |
(dollars in thousands) | 2022 | | 2021 | | 2020 |
United States | $ | 689,341 | | | $ | 705,908 | | | $ | 616,135 | |
United Kingdom | $ | 35,719 | | | $ | 56,546 | | | $ | (25,776) | |
Bermuda | $ | (144,239) | | | $ | 556,275 | | | $ | 228,740 | |
Germany | $ | (2,471) | | | $ | 1,780 | | | $ | (4,628) | |
Amounts presented for the Company's U.S. insurance subsidiaries have been calculated in accordance with prescribed statutory accounting rules. For the Company's international insurance subsidiaries, the regulations that govern the calculation of statutory capital and surplus do not provide requirements for the calculation of net income. Rather, such amounts are reported in accordance with a basis of accounting permitted by their respective regulator. Amounts presented for the Company's U.K., Bermuda and German insurance subsidiaries have been calculated in accordance with U.K. GAAP, U.S. GAAP and German GAAP, respectively.
United States
The laws of the domicile states of the Company's U.S. insurance subsidiaries govern the amount of dividends that may be paid to the Company. Generally, statutes in the domicile states of the Company's U.S. insurance subsidiaries require prior approval for payment of extraordinary, as opposed to ordinary, dividends. As of December 31, 2022, the Company's U.S. insurance
subsidiaries could pay up to $655.6 million to the holding company during the following 12 months under the ordinary dividend regulations.
In converting from U.S. statutory accounting principles to U.S. GAAP, typical adjustments include deferral of policy acquisition costs, differences in the calculation of deferred income taxes and the inclusion of net unrealized gains or losses relating to fixed maturity securities in shareholders' equity. The Company does not use any permitted statutory accounting practices that are different from prescribed statutory accounting practices which impact statutory capital and surplus.
United Kingdom
The Company's U.K. insurance subsidiary, Markel International Insurance Company Limited (MIICL), and its Lloyd's managing agent, Markel Syndicate Management Limited (MSM), are authorized by the Prudential Regulation Authority (PRA) and regulated by both the PRA and the Financial Conduct Authority (FCA). The PRA oversees compliance with established periodic auditing and reporting requirements, minimum solvency margins and individual capital assessment requirements under the Solvency II Directive (Solvency II) and imposes dividend restrictions, while both the PRA and the FCA oversee compliance with risk assessment reviews and various other requirements. MIICL is required to give advance notice to the PRA for any transaction or proposed transaction with a connected or related person. MSM is required to satisfy the solvency requirements of Lloyd's. In addition, the Company's U.K. subsidiaries must comply with the United Kingdom Companies Act of 2006, which provides that dividends may only be paid out of profits available for that purpose. Earnings of the Company's U.K. insurance subsidiaries are available for distribution to the holding company to the extent not otherwise restricted.
Bermuda
The Company's Bermuda insurance subsidiary, Markel Bermuda Limited (MBL), is subject to enhanced capital requirements in addition to minimum solvency and liquidity requirements. The enhanced capital requirement is determined by reference to a risk-based capital model that determines a control threshold for statutory capital and surplus by taking into account the risk characteristics of different aspects of the insurer's business. At December 31, 2022, MBL satisfied both the enhanced capital requirements and the minimum solvency and liquidity requirements.
Under the Bermuda Insurance Act, MBL is prohibited from paying or declaring dividends during a fiscal year if it is in breach of its enhanced capital requirement, solvency margin or minimum liquidity ratio or if the declaration or payment of the dividend would cause a breach of those requirements. If an insurer fails to meet its solvency margin or minimum liquidity ratio on the last day of any financial year, it is prohibited from declaring or paying any dividends during the next financial year without the approval of the Bermuda Monetary Authority (BMA). Further, MBL is prohibited from declaring or paying, in any financial year, dividends of more than 25% of its total statutory capital and surplus as set forth in its previous year's statutory balance sheet unless at least seven days before payment of those dividends it files with the BMA an affidavit stating that it will continue to meet its solvency margin and minimum liquidity ratio. MBL must obtain the BMA's prior approval for a reduction by 15% or more of the total statutory capital as set forth in its previous year's financial statements. In addition, as a long-term insurer, MBL may not declare or pay a dividend to any person other than a policyholder unless the value of the assets in its long-term business fund, as certified by MBL's approved actuary, exceeds the liabilities of its long-term business. The amount of the dividend cannot exceed the aggregate of that excess and any other funds legally available for the payment of the dividend. As of December 31, 2022, MBL could pay up to $473.8 million to the holding company during the following 12 months without making any additional filings with the BMA.
Germany
The Company's German insurance subsidiary, Markel Insurance SE, is regulated by the Federal Financial Conduct Authority in Germany and is also subject to capital and solvency requirements under Solvency II.
b) Lloyd's sets the corporate members' required capital annually based on each syndicates' business plans, rating environment, reserving environment and input arising from Lloyd's discussions with, among others, regulatory and rating agencies. Such required capital is referred to as Funds at Lloyd's (FAL) and comprises cash and investments. The amount of cash and investments held as FAL as of December 31, 2022 was $873.0 million. Of this amount, $335.4 million was provided by the holding company and is not available for general use by the Company. The remaining amount, provided by the Company's insurance subsidiaries, is not available for distribution to the holding company. The Company's corporate member may also be required to maintain funds under the control of Lloyd's in excess of its capital requirements and such funds also may not be available for distribution to the holding company.
23. Markel Corporation (Parent Company Only) Financial Information
The following parent company only condensed financial information reflects the financial position, results of operations and cash flows of Markel Corporation.
CONDENSED BALANCE SHEETS
| | | | | | | | | | | |
| December 31, |
| 2022 | | 2021 |
| (dollars in thousands) |
ASSETS | | | |
Investments, at estimated fair value: | | | |
Fixed maturity securities, available-for-sale (amortized cost of $164,100 in 2022 and $210,111 in 2021) | $ | 154,039 | | | $ | 228,705 | |
Equity securities (cost of $1,107,796 in 2022 and $1,771,597 in 2021) | 1,473,116 | | | 2,784,189 | |
Short-term investments, available-for-sale (estimated fair value approximates cost) | 1,436,387 | | | 1,474,997 | |
Total Investments | 3,063,542 | | | 4,487,891 | |
Cash and cash equivalents | 594,101 | | | 763,985 | |
Restricted cash and cash equivalents | 21,146 | | | 15,485 | |
Receivables | 13,070 | | | 18,770 | |
Investments in consolidated subsidiaries | 12,905,353 | | | 13,298,971 | |
Notes receivable from subsidiaries | 60,111 | | | 135,756 | |
Income taxes receivable | — | | | 48,344 | |
Other assets | 445,875 | | | 408,161 | |
Total Assets | $ | 17,103,198 | | | $ | 19,177,363 | |
LIABILITIES AND SHAREHOLDERS' EQUITY | | | |
Senior long-term debt | $ | 3,686,892 | | | $ | 4,034,223 | |
Notes payable to subsidiaries | — | | | 32,753 | |
Income taxes payable | 120,616 | | | — | |
Net deferred tax liability | 148,365 | | | 295,289 | |
Other liabilities | 81,791 | | | 97,748 | |
Total Liabilities | 4,037,664 | | | 4,460,013 | |
Shareholders' equity: | | | |
Preferred stock | 591,891 | | | 591,891 | |
Common stock | 3,493,893 | | | 3,441,079 | |
Retained earnings | 9,836,827 | | | 10,446,763 | |
Accumulated other comprehensive income (loss) | (857,077) | | | 237,617 | |
Total Shareholders' Equity | 13,065,534 | | | 14,717,350 | |
Total Liabilities and Shareholders' Equity | $ | 17,103,198 | | | $ | 19,177,363 | |
CONDENSED STATEMENTS OF INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS)
| | | | | | | | | | | | | | | | | |
| Years Ended December 31, |
| 2022 | | 2021 | | 2020 |
| (dollars in thousands) |
REVENUES | | | | | |
Net investment income | $ | 34,781 | | | $ | 9,099 | | | $ | 22,037 | |
Dividends on common stock of consolidated subsidiaries | 278,557 | | | 1,081,988 | | | 466,244 | |
Net investment gains (losses): | | | | | |
| | | | | |
Net realized investment gains | 7,620 | | | 23,652 | | | 27,774 | |
Change in fair value of equity securities | (397,906) | | | 514,727 | | | 82,389 | |
Net investment gains (losses) | (390,286) | | | 538,379 | | | 110,163 | |
Gain on sale of subsidiary | 107,293 | | | — | | | — | |
Other revenues (losses) | (29,487) | | | 11,078 | | | (4,011) | |
Total Revenues | 858 | | | 1,640,544 | | | 594,433 | |
EXPENSES | | | | | |
Services and other expenses | 111,848 | | | 22,379 | | | 1,025 | |
Interest expense | 172,125 | | | 185,568 | | | 187,562 | |
Net foreign exchange losses (gains) | (13,143) | | | (6,236) | | | 6,823 | |
| | | | | |
Total Expenses | 270,830 | | | 201,711 | | | 195,410 | |
Income (Loss) Before Equity in Undistributed Earnings (Losses) of Consolidated Subsidiaries and Income Taxes | (269,972) | | | 1,438,833 | | | 399,023 | |
Equity in undistributed earnings (losses) of consolidated subsidiaries | (69,971) | | | 1,081,976 | | | 400,289 | |
Income tax (expense) benefit | 125,820 | | | (95,806) | | | 16,718 | |
Net Income (Loss) to Shareholders | (214,123) | | | 2,425,003 | | | 816,030 | |
Preferred stock dividends | (36,000) | | | (36,000) | | | (18,400) | |
Net Income (Loss) to Common Shareholders | $ | (250,123) | | | $ | 2,389,003 | | | $ | 797,630 | |
OTHER COMPREHENSIVE INCOME (LOSS) TO SHAREHOLDERS | | | | | |
Change in net unrealized gains (losses) on available-for-sale investments, net of taxes: | | | | | |
Net holding gains (losses) arising during the period | $ | (24,465) | | | $ | (5,885) | | | $ | 21,482 | |
Consolidated subsidiaries' net holding gains (losses) arising during the period | (1,130,589) | | | (342,430) | | | 334,677 | |
| | | | | |
Reclassification adjustments for net gains (losses) included in net income (loss) to shareholders | 1,965 | | | (34) | | | (14,937) | |
Consolidated subsidiaries' reclassification adjustments for net gains (losses) included in net income (loss) to shareholders | 42,941 | | | (6,589) | | | 11,551 | |
Change in net unrealized gains (losses) on available-for-sale investments, net of taxes | (1,110,148) | | | (354,938) | | | 352,773 | |
| | | | | |
Consolidated subsidiaries' change in foreign currency translation adjustments, net of taxes | (9,276) | | | (211) | | | 29,829 | |
Consolidated subsidiaries' change in net actuarial pension loss, net of taxes | 24,730 | | | 8,390 | | | (6,998) | |
Total Other Comprehensive Income (Loss) to Shareholders | (1,094,694) | | | (346,759) | | | 375,604 | |
Comprehensive Income (Loss) to Shareholders | $ | (1,308,817) | | | $ | 2,078,244 | | | $ | 1,191,634 | |
CONDENSED STATEMENTS OF CASH FLOWS
| | | | | | | | | | | | | | | | | |
| Years Ended December 31, |
| 2022 | | 2021 | | 2020 |
| (dollars in thousands) |
OPERATING ACTIVITIES | | | | | |
Net income (loss) to shareholders | $ | (214,123) | | | $ | 2,425,003 | | | $ | 816,030 | |
Adjustments to reconcile net income (loss) to shareholders to net cash provided by operating activities | 487,259 | | | (2,213,261) | | | (708,162) | |
Net Cash Provided By Operating Activities | 273,136 | | | 211,742 | | | 107,868 | |
INVESTING ACTIVITIES | | | | | |
Proceeds from sales, maturities, calls and prepayments of fixed maturity securities | 13,047 | | | 37,607 | | | 319,502 | |
| | | | | |
Proceeds from sales of equity securities | 65,379 | | | 105,700 | | | 276,637 | |
Cost of equity securities purchased | (16,660) | | | (73,644) | | | (90,459) | |
Net change in short-term investments | 58,970 | | | (224,646) | | | (522,666) | |
Return of capital from subsidiaries | — | | | 17,193 | | | 15,164 | |
Decrease (increase) in notes receivable due from subsidiaries | 75,645 | | | (50,000) | | | (25,000) | |
Capital contributions to subsidiaries (1) | (94,585) | | | (271,729) | | | (605,426) | |
Proceeds from sale of subsidiary | 165,615 | | | — | | | — | |
| | | | | |
Cost of equity method investments | — | | | (38,550) | | | (4,917) | |
Other | 4,779 | | | (5,368) | | | 17,984 | |
Net Cash Provided (Used) By Investing Activities | 272,190 | | | (503,437) | | | (619,181) | |
FINANCING ACTIVITIES | | | | | |
Repayment of senior long-term debt | (350,000) | | | — | | | — | |
Additions to senior long-term debt | — | | | 591,354 | | | — | |
Decrease in notes payable to subsidiaries | (32,753) | | | — | | | (50,000) | |
| | | | | |
Repurchases of common stock | (290,796) | | | (206,518) | | | (26,832) | |
Issuance of preferred stock, net | — | | | — | | | 591,891 | |
Dividends paid on preferred stock | (36,000) | | | (36,000) | | | (18,400) | |
Other | — | | | (1,181) | | | 15 | |
Net Cash Provided (Used) By Financing Activities | (709,549) | | | 347,655 | | | 496,674 | |
Increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents | (164,223) | | | 55,960 | | | (14,639) | |
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of year | 779,470 | | | 723,510 | | | 738,149 | |
CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS AT END OF YEAR | $ | 615,247 | | | $ | 779,470 | | | $ | 723,510 | |
(1) The holding company made non-cash capital contributions in the form of investments to its subsidiaries totaling $924.0 million and $49.5 million for the years ended December 31, 2022 and 2020, respectively. There were no non-cash capital contributions made to subsidiaries for the year ended December 31, 2021.
24. Immaterial Correction to Prior Period Financial Statements for Accounting Policy Change
The Company defers and amortizes costs directly related to the successful acquisition of new or renewal insurance contracts over the related policy period, generally one year. Previously, the Company did not defer salaries and benefits associated with the successful acquisition of insurance contracts, as such amounts were quantified and assessed each period and were deemed not to be material to the consolidated financial statements. Effective January 1, 2022, the Company changed its accounting policy to defer salaries and benefits associated with the successful acquisition of insurance contracts in accordance with the requirements of FASB ASC 944, Financial Services–Insurance.
To reflect the change in accounting policy, the Company made a cumulative adjustment to increase deferred policy acquisition costs by $28.2 million, increase deferred tax liabilities by $5.9 million and increase retained earnings by $22.3 million as of January 1, 2020, which is the beginning of the earliest year presented in the consolidated financial statements included herein. These increases in deferred policy acquisition costs, deferred tax liabilities and retained earnings are reflected as increases to the previously reported amounts in the Company's consolidated balance sheet as of December 31, 2021 and as an adjustment to retained earnings as of January 1, 2020 in the accompanying consolidated statement of changes in equity for the year ended December 31, 2020. The Company considered both the quantitative and qualitative factors within the provisions of U.S. Securities and Exchange Commission Staff Accounting Bulletin (SAB) No. 99, Materiality, and SAB No. 108, Considering the Effect of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements and determined that the impact of the change in accounting policy was not material to the Company's previously issued consolidated financial statements. The Company did not adjust the amounts previously presented in the consolidated statements of income and comprehensive income for the years ended December 31, 2020 and 2021 for the change in accounting policy as the effects were not material. The cumulative income statement effect for those periods was included in the consolidated statement of loss and comprehensive loss for the year ended December 31, 2022.